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Depressed adults are at increased risk of developing atherosclerotic cardiovascular 
disease (CVD). However, heterogeneity in the depressed population engenders a key question: 
Are there subgroups of depressed adults at greater risk of developing CVD? Because other 
affective traits – i.e., anxiety, hostility/anger, and low trait positive affect – have also been 
associated with increased CVD risk, depressed adults with higher levels of these co-occurring 
affective traits may have an elevated risk of developing CVD. Consequently, the present study’s 
first aim was to examine, in depressed adults, which affective traits (depression, anxiety, 
hostility/anger, or low positive affect) are associated with endothelial function, a marker of 
cumulative CVD risk. In addition, because the other affective traits overlap with depressive 
symptom severity, this study’s second aim was to investigate which components of pairs of 
affective traits (shared versus unique) are related to endothelial function. Finally, given that the 
mechanisms underlying affective trait-endothelial function relationships in depressed adults are 
unknown, this study’s third aim was to explore traditional CVD risk status as a candidate 
mediator of observed relationships. To achieve these aims, I combined pre-treatment, cross-
sectional data from three randomized controlled trials involving 138 depressed primary care 
patients with no history of clinical CVD. Assessments included validated self-report 
questionnaires for affective traits, brachial artery flow-mediated dilation (FMD) for endothelial 
function, and 10-year Framingham risk score for traditional CVD risk status. I conducted 
structural equation modeling (SEM) with confirmatory factor analysis to examine the
    ix 
relationships of interest after adjusting for age, sex, race/ethnicity, education, and baseline 
arterial diameter. Although the shared variance between each affective trait pair could not be 
modeled due to poor fit, adequate fitting models revealed that hostility/anger and the unique 
components of hostility/anger were associated with poorer endothelial function (standardized 
coefficients = -.18 and -.22, respectively). All of the other affective traits and their components 
(depression, anxiety, positive affect, unique depression, unique anxiety, and unique positive 
affect) were not related to endothelial function (all ps > .08). Traditional CVD risk status did not 
partially explain the relationship between the unique components of hostility/anger and 
endothelial function (standardized coefficient for the indirect effect = .00; p = .89). If my results 
are supported by future findings, it would suggest that depressed adults with hostility/anger (a) 
may be a subgroup of the depressed population at greater risk of developing CVD and (b) may 
be in need of earlier, more intense, and/or different CVD primary prevention efforts. Future 
studies are needed to confirm this relationship and identify underlying mechanisms. 
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INTRODUCTION 
Cardiovascular Disease 
Epidemiology of Cardiovascular Disease 
Cardiovascular disease (CVD), which refers to disorders of the heart and the vascular 
system, is highly prevalent, deadly, and costly (Mozaffarian et al., 2015). Approximately one in 
three American adults has at least one type of CVD. In 2011, CVD accounted for 31% of all 
deaths in the U.S., making it the leading cause of mortality. In addition, the cost of CVD exceeds 
that of any other health condition. The estimated annual cost of CVD in 2011 was $320 billion. 
Due to the high prevalence and costs of CVD, the need for primary prevention efforts is greater 
now than ever before. Among the preventive strategies recommended by the American Heart 
Association, and of relevance to the present study, is the early detection and management of 
CVD risk factors (Heidenreich et al., 2011). 
Pathophysiology of Atherosclerotic Cardiovascular Disease 
Although CVD encompasses a variety of conditions, the present study will focus on 
atherosclerotic CVD, a progressive systemic disease involving the thickening and hardening of 
blood vessels in the heart, brain, and peripheral circulation (Santos & Nasir, 2009). Injury to 
endothelium – the single layer of cells lining the blood vessels –instigates the process of 
atherosclerosis by increasing the adhesiveness and permeability of the vessel walls (Santos & 
Nasir, 2009). As a result, lipids flowing in the bloodstream begin to accumulate as deposits 
(Santos & Nasir, 2009). Chemical modifications to these lipid deposits result in endothelial 
dysfunction, a state of the endothelium characterized by decreased production/availability of 
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vasodilators (particularly nitric oxide) and/or increased production/availability of 
vasoconstrictors (Hadi, Carr, & Suwaidi, 2005). This imbalance leads to a reduced ability of the 
vascular lining to maintain normal homeostasis – namely, impairment of endothelium-dependent 
vasodilation (Corretti et al., 2002). In addition to impairment in endothelium-dependent 
vasodilation, the proinflammatory, proliferative, and procoagulatory state of endothelial 
dysfunction acts to promote downstream atherosclerotic processes, including structural changes 
in vascular walls (lesion formation and calcification) that narrow and harden blood vessels 
(Davignon, & Ganz, 2004; Hadi et al., 2005). These structural changes can (a) impede blood 
flow and reduce oxygen supply to tissues and (b) promote increased velocity and turbulence of 
blood flow, which can cause lesions to rupture (Zipes, Libby, Bonow, & Braunwald, 2004). A 
blood clot (thrombus) may develop at the site of ruptured lesions (Zipes et al., 2004). Thrombi or 
dislodged thrombi that travel through the circulation (emboli) can partially or completely block 
blood flow to regions of the heart or the brain (Zipes et al., 2004). 
Atherosclerosis can progress asymptomatically for decades (subclinical atherosclerosis) 
but can eventually result in fatal and nonfatal CVD events, including heart tissue death 
(myocardial infarction; MI), brain tissue death (stroke), insufficient blood flow to the heart and 
chest pain (cardiac ischemia and angina pectoris), and sudden cessation of heartbeat and cardiac 
function (cardiac arrest; Libby, 2004). The first occurrence of one or more of these clinical 
events signifies the onset of clinical CVD. Notably, the current study sample is comprised of 
adults free of clinical CVD.  
Assessment of Atherosclerotic Cardiovascular Disease 
Empirical studies have utilized several measures of CVD, including indicators of clinical 
CVD and subclinical atherosclerosis. The vast majority of cardiovascular behavioral medicine 
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research has examined whether psychosocial factors predict future CVD events (Matthews, 
2005). However, it is possible that psychosocial factors exert a stronger cardiotoxic effect earlier 
in the atherosclerotic process (Matthews, 2005). To examine the earlier stages of CVD, 
noninvasive imaging technologies can be utilized to measure early to late stages of subclinical 
atherosclerosis (Santos & Nasir, 2009). These technologies can measure structural or functional 
characteristics of subclinical atherosclerosis (Bisoendial et al., 2002). 
The present study examines a functional measure of subclinical atherosclerosis: 
endothelial function assessed by flow-mediated dilation (FMD) of the brachial artery. This 
measure quantifies the degree of impairment in endothelium-dependent vasodilation (Corretti et 
al., 2002). Examining endothelial function in the current study is advantageous for several 
reasons. One, endothelial dysfunction is detectable early in the development of subclinical 
atherosclerosis yet also promotes progression of subclinical atherosclerosis across all stages of 
the disease (Hadi et al., 2005). Two, endothelial dysfunction is thought to be the final common 
pathway through which CVD risk factors promote subclinical atherosclerosis (Frick & 
Weidinger, 2007; Vita & Keaney, 2002) and, accordingly, is considered a marker of cumulative 
CVD risk (Hadi et al., 2005). Three, endothelial dysfunction (a) has been observed in adults with 
CVD risk factors but no detectable disease (Celermajer et al., 1992) and (b) is an independent 
predictor of CVD events among initially healthy persons (Schindler et al., 2003; Yeboah et al., 
2009) and among those with elevated CVD risk (Perticone et al., 2001; Rossi, Nuzzo, Origliani, 
& Modena, 2008).  
Endothelial function can be assessed in the coronary and peripheral arteries (Hadi et al., 
2005). The gold standard test for the evaluation of endothelial function requires invasive 
infusions of endothelium-dependent vasodilators (e.g., acetylcholine) into the coronary arteries 
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(Hadi et al., 2005). However, this method is limited due to its invasive nature. Consequently, 
noninvasive techniques have also been developed to assess endothelial function. While multiple 
noninvasive measures exist, brachial artery flow-mediated dilation (FMD) is the preferred 
noninvasive measure of endothelial function (Deanfield et al., 2007). This technique utilizes 
high-resolution ultrasound to measure the degree to which the brachial artery dilates in response 
to increased blood flow induced by the release of a blood pressure cuff (Thurston, Rewak, & 
Kubzansky, 2013). 
Traditional Risk Factors for Cardiovascular Disease 
A number of CVD risk factors are well established in the literature. Non-modifiable risk 
factors for CVD are older age, male sex, African American race, and a positive family history of 
CVD (Mozaffarian et al., 2015). Modifiable CVD risk factors have also been identified in the 
biological (dyslipidemia, hypertension, diabetes, and obesity) and behavioral (tobacco use, 
physical inactivity, and poor diet) domains (Yusuf, Reddy, Ôunpuu, & Anand, 2001). However, 
even when considering all of these traditional CVD risk factors, it is estimated that half of the 
variance in CVD events remains unexplained (Yusuf et al., 2001). Moreover, cross-sectional 
evidence suggests that greater than 60% of the variance in subclinical atherosclerosis is 
unexplained by traditional CVD risk factors (Santos et al., 2015). Consequently, it is crucial to 
further our understanding of emerging CVD risk factors, such as depression, that may account 
for a portion of this unexplained variance. 
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Depression as a Risk Factor for Cardiovascular Disease 
Depression 
Depressive disorders are common conditions (the lifetime prevalence is 16.5% for major 
depressive disorder [MDD] and 2.5% for dysthymic disorder; Kessler et al., 2005) that impact a 
person’s affective, cognitive, behavioral, and physiological functioning (Pratt & Brody, 2008). 
Symptoms of depressive disorders are depressed mood, loss of interest/pleasure, appetite/weight 
changes, sleep disturbances, psychomotor retardation/agitation, feelings of worthlessness or 
guilt, fatigue, concentrations problems, and suicidal ideation (American Psychiatric Association, 
2013). Depression can be conceptualized and measured as a dichotomous disorder diagnosis or a 
continuous symptom severity. Of note, depressive symptom severity is relatively stable over 
time. To illustrate, test-retest correlations for measures of depressive symptom severity indicate 
stability over one year (r range: 0.61-0.72), two to three years (r range: 0.55 to 0.61), and six 
years (r range: 0.52-0.55; Brown, 2007; Wetherell, Gatz, & Pedersen, 2001). 
Depression and Cardiovascular Disease 
A substantial literature supports depression as one emerging risk factor for CVD. For 
example, a meta-analysis of 11 high-quality prospective studies revealed that, compared to adults 
without depression, those with a depressive disorder or elevated depressive symptoms are at a 
54% increased risk for incident CVD (Van der Kooy et al., 2007) after controlling for traditional 
CVD risk factors. This depression-CVD relationship has been detected in men and women and in 
various age and racial/ethnic groups (Brown, Stewart, Stump & Callahan, 2011; Rosengren et al., 
2004; Stewart et al., 2012; Van der Kooy et al., 2007). Moreover, the magnitude of the 
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relationship between depression and CVD is comparable in strength to traditional CVD risk 
factors (Wilson et al., 1998). 
Literature also supports relationships of depressive disorders and depressive symptom 
severity with subclinical atherosclerosis. Studies have found depressive symptoms to 
prospectively predict structural measures of subclinical atherosclerosis, such as progression of 
coronary artery calcification (Janssen et al., 2011; Stewart et al., 2012) and carotid intima-media 
thickness (Stewart, Janicki, Muldoon, Sutton-Tyrrell, & Kamarck, 2007). Additionally, one 
study found that, compared to adults without MDD, those with MDD have greater progression of 
coronary artery calcification (Matthews et al., 2010). Studies also support the relationship 
between depression and functional measures of subclinical atherosclerosis. Of relevance here, a 
meta-analysis of 12 studies indicates that depression is related to poorer endothelial function 
(Cooper, Tomfohr, & Milic, 2011). Specifically, this meta-analysis found a significant 
relationship between depression (defined as either MDD [k = 5] or depressive symptom severity 
[k = 7]) and worse brachial FMD (r = 0.19) that was stronger in the six high-quality studies (r = 
0.29; in this meta-analysis r conveys effect size but not directionality; Cooper et al., 2011).  
Variability in the Relationship between Depression and Cardiovascular Disease 
There is a high degree of heterogeniety in the depressed population (Fried & Nesse, 
2015). For instance, because depression is comprised of affective, cognitive, behavioral, and 
somatic components, symptom presentation can vary across depressed adults. Those with 
depression can also vary with regard to severity, chronicity, and subtype of depressive disorder. 
In addition, the presense or absense of comorbid psychiatric conditions (e.g., anxiety disorders) 
may also vary across depressed people. Thus, it is possible that the degree of excess CVD risk 
conferred by depression varies within this heterogenious population (Davidson, Rieckmann, & 
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Rapp, 2005). This engenders a key question: Are there subgroups of depressed people at greater 
risk of developing CVD than others? Initial research in this area has sought to identify which 
clusters of depressive symptoms (e.g., cognitive-affective versus somatic), what severity and 
chronicity presentations (e.g., recurrent versus single episode MDD), and which depressive 
disorder subtypes (e.g., atypical versus nonatypical depression) are associated with the greatest 
risk of developing CVD. 
Evidence suggests that the CVD risk conferred by depression varies across depressive 
symptom clusters (Pratt & Brody, 2008). For instance, a recent investigation of older adults 
found that, when all depressive symptom clusters were modeled together, the somatic cluster – 
but not the depressed affect, interpersonal problems, or (lack of) positive affect clusters – 
predicted 15-year incidence of coronary artery disease (Hawkins, Callahan, Stump, & Stewart, 
2014). Similariliy, in another study of older adults, the somatic-vegetative cluster, but not the 
cognitive-affective cluster, was a preditor of 3-year progression of carotid intima-media 
thickness (Stewart et al., 2007). In contrast to these previous findings, a study of middle-aged 
adults revealed that only the depressed affect cluster predicted 5-year incidence of coronary 
artery calcification (Stewart et al., 2012). In this study, the somatic symptoms, interpersonal 
problems, and (lack of) positive affect clusters were not associated with coronary artery 
calcification. These varying results may be due to differences in the age of the study sample (i.e., 
older adults versus middle-aged adults). Nonetheless, these studies suggest that the depressive 
symptom clusters may confer differential CVD risk. 
Another line of research suggests that the severity and chronicity of depression also 
influences the degree of CVD risk conferred by depression. First, there appears to be a graded 
relationship between depression severity and CVD risk (Rugulies, 2002). Supporting this notion, 
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minor depression is associated with a 1- to 2-fold increase in CVD risk, whereas major 
depression is associated with a 3- to 5-fold increase in risk (Bunker et al., 2003). Moreover, one 
study found that moderate/severe depressive symptoms, but not mild symptoms, predicted 
increases in carotid intima-media thickness over time (Pizzi et al., 2014). Second, greater 
chronicity also appears to be associated with increased CVD risk. For example, a recent study 
found that recurrent MDD (HR = 1.85, 95% CI: 1.02-3.36), but not single episode MDD (HR = 
1.23, 95% CI: 0.62-2.43), predicted 6-year incidence of CVD (Seldenrijk et al., 2015).  
Finally, CVD risk may be greatest for certain subtypes of depressive disorders. For 
instance, one study found that lifetime atypical MDD (MDD with reversed somatic-vegetative 
symptoms of hyperphagia and hypersomnia; Quitkin, 2002) was associated with a greater risk of 
incident CVD than lifetime nonatypical MDD, lifetime dysthymic disorder, and no depression 
history groups (Case, Sawhney, & Stewart, 2018). Results further revealed that double 
depression (MDD superimposed on dysthymic disorder; Keller & Shapiro, 1982) was associated 
with a greater risk of incident CVD than MDD only, dysthymic disorder only, and no depression 
history groups (Case et al., 2018). Therefore, this study suggests that adults with atypical or 
double depression may be two subgroups at a heightened risk of developing CVD. 
To summarize, only recently have investigators begun to examine which depressed adults 
are at greatest risk of developing CVD. Initial research suggests that symptom presentation, 
severity, chronicity, and subtype may all influence the degree of CVD risk in depressed adults. 
Of key interest to the present study are affective traits (anxiety, hostility/anger, and low positive 
affect) that often co-occur with depression and that may put depressed adults at elevated risk of 
developing CVD (Suls & Bunde, 2005). In the following section, I will review these affective 
traits that overlap with depression and their potential to elevate the CVD risk of depressed adults. 
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Affective Traits that Overlap with Depression and Predict Cardiovascular Disease 
In addition to the depression-CVD literature, a growing body of evidence suggests that 
other affective traits – i.e., anxiety, hostility/anger, and low positive affect – predict the 
development of CVD. Importantly, adults with depression are likely to experience co-occurring 
anxiety, hostility/anger, and low positive affect. Therefore, depressed adults with higher levels of 
these co-occurring affective traits may be at greater risk of developing CVD than those with 
lower levels of these traits. In this section, I review anxiety, hostility/anger, and low positive 
affect with respect to (a) their overlap with depression, (b) their relationship with CVD risk in 
the general population, and (c) their relationship with CVD risk in depressed adults. 
Anxiety  
Anxiety disorders are common conditions (the lifetime prevalence of any anxiety 
disorder is 28%; Kessler et al., 2005) that involve symptoms of excessive fear and anxiety as 
well as related behavioral disturbances (American Psychiatric Association, 2013). Symptoms of 
anxiety are thought to arise from a perceived sense of future threat or danger (Barlow, 2004). 
However, anxiety disorders – such as generalized anxiety disorder, panic disorder, and phobias – 
are each unique regarding the type of objects or situations that induce symptoms (American 
Psychiatric Association, 2013). Anxiety can be conceptualized and measured as a dichotomous 
disorder diagnosis or a continuous symptom severity. As is the case with depression, anxiety 
symptom severity is relatively stable over time. Test-retest correlations for measures of anxiety 
symptom severity suggest stability over one year (r range: 0.66-0.69), two to three years (r 
range: 0.58-0.62) and six years (r range: 0.55-0.61; Brown et al., 2007; Wetherell et al., 2001). 
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Overlap Between Anxiety and Depression 
The symptoms of anxiety and depression overlap considerably (Mineka, Watson, & 
Clark, 1998; Clark & Watson, 1991). Correlations between self-report measures of depression 
and anxiety symptoms are typically moderate to large (r range: 0.45-0.75; Watson et al., 1995). 
Moreover, adults with depressive disorders are likely to experience comorbid anxiety disorders 
(Mineka et al., 1998). For instance, a large cohort study found that, of those with a current 
depressive disorder, 67% and 75% met criteria for a current and lifetime anxiety disorder, 
respectively (Lamers et al., 2011). Results of numerous studies indicate that the presence of 
anxiety in depressed adults is associated with increased depression severity, greater depression 
chronicity, higher relapse rates, and reduced psychosocial functioning (Mineka et al., 1998). 
Anxiety and Cardiovascular Disease Risk in the General Population 
Evidence suggests that adults with anxiety disorders or elevated anxiety symptoms are at 
increased risk of developing CVD (Thurston et al., 2013). A recent meta-analysis of 34 
prospective studies revealed that adults with anxiety have a 50% greater risk of incident CVD 
compared to those without anxiety after adjustment for traditional CVD risk factors (Batelaan, 
Seldenrijk, Bot, van Balkom, & Penninx, 2016). Additionally, results of this meta-analysis 
revealed that the prospective effect of anxiety on CVD outcomes did not significantly differ 
between studies that adjusted for/excluded depression (k = 14; pooled HR = 1.57, 95% CI: 1.29-
1.90) and studies that did not (k = 25; pooled HR = 1.47, 95% CI: 1.30-1.65; Batelaan et al., 
2016). This suggests that the relationship between anxiety and incident CVD is independent from 
depression in the general population. 
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Compared to this anxiety-clinical CVD literature, fewer studies have investigated the 
relationship between anxiety and measures of subclinical atherosclerosis, and the findings have 
been mixed. For instance, of the two longditudinal studies in this literature, one found that higher 
anxiety symptom severity predicts 4-year progression of carotid intima-media thickness (but not 
coronary artery calcification) in both men and women and more plaque formation in men only 
(Paterniti et al., 2001). The other study found no relationship between anxiety symptom severity 
and 3-year progresion of carotid intima-media thickness both before and after controlling for 
depressive symptom severity (Stewart et al., 2007). Cross-sectional relationships between 
anxiety and arterial stiffness are also weakly supported. While two studies found that anxiety is 
associated with increased arterial stiffness (Cicek et al., 2012; Seldenrijk, van Hout, van 
Marwijk, de Groot, & Gort, 2011), two other studies observed no relationship (Lewis et al., 
2010; Nomura, Nakao, Karita, Nishikitani, & Yano, 2005). Overall, relationships between 
anxiety and structural measures of subclinical atherosclerosis are inconsistent. 
The relationship between anxiety and functional measures of subclinical atherosclerosis 
have also been inconsistent (Thurston et al., 2013). Although two studies did not detect an 
association between anxiety and endothelial function (Routledge et al., 2017; Schott, Kamarck, 
Matthews, Brockwell, & Sutton-Tyrrell, 2009), three other investigations have found that anxiety 
symptom severity was associated with poorer endothelial function (Cooper et al., 2010; Harris, 
Matthews, Sutton-Tyrrell, & Kuller, 2003; Narita et al., 2007). Another study found that post-
traumatic stress disorder, a condition which often includes severe anxiety, was associated with 
worse endothelial function in veterans (Grenon et al., 2016). Overall, the relationship between 
anxiety and subclinical atherosclerosis has been most consistent for endothelial function. 
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However, none of these studies accounted for the potential of depressive symptom severity to 
confound anxiety-endothelial function relationships. 
Anxiety and Cardiovascular Disease in Depressed Adults 
Two investigations have examined the influence of anxiety on incident CVD in depressed 
adults. The first of these studies, a longditudinal case-control study of patients with and without 
panic disorder (Gomez-Caminero et al., 2005), found that panic disorder was related to incident 
CVD to a greater degree in depressed adults (HR = 2.61, 95% CI: 2.32-2.95) than in 
nondepressed adults (HR = 1.86, 95% CI: 1.82-1.89). A second study found that panic disorder 
(HR = 1.22, 95% CI: 1.07-1.39) and anxiety disorder unspecified (HR = 1.11, 95% CI: 1.03-
1.20) – but not generalized anxiety disorder, social phobia, or post-traumatic stress disorder – 
predicted incident CVD in depressed veterans (Scherrer et al., 2010). These studies suggest that 
some types of anxiety disorders, but perhaps not others, increase CVD risk in depressed adults. 
However, neither accounted for the potential confounder of depressive symptom severity. 
Other studies have examined the relationship between comorbid depressive and anxiety 
disorders, depressive disorder only, anxiety disorder only, and neither disorder (reference 
category) with CVD outcomes. Four of these studies have examined incident CVD outcomes 
(Berecki-Gisolf, McKenzie, Dobson, McFarlane, & McLaughlin, 2013; Garfield et al., 2014; 
Phillips et al., 2009; Seldenrijk et al., 2015). In all four studies, the magnitude of CVD risk was 
greatest for the adults with comorbid depression and anxiety. Moreover, in two of these studies, 
only adults with comorbid depressive and anxiety disorders were at increased CVD risk 
(Berecki-Gisolf et al., 2013; Phillips et al., 2009).  
Two other studies have also examined the cross-sectional relationship between comorbid 
depression and anxiety and measures of subclinical atheroscerosis. One study found that adults 
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with comorbid depressive and anxiety disorders, but not those with a depressive or anxiety 
disorder only, had greater arterial stiffness than adults without depressive or anxiety disorders 
(Seldenrijk et al., 2011). In constrast, another study found that ankle-brachial index (the ratio of 
ankle to arm blood pressure, where lower scores indicate peripheral artery disease) was 
comparable across those with current depressive disorder only, current anxiety disorder only, and 
comorbid depressive and anxiety disorders. Specifically, all three groups had a 2-3 fold increased 
risk of low ankle-brachial index compared to the group with no depressive or anxiety disorders 
(Seldenrijk et al., 2010).  
Taken together, the majority of this evidence has found a numerically greater degree of 
CVD risk in depressed adults with versus without comorbid anxiety. Of note, I use the word 
“numerically” because those with comorbid depressive and anxiety disorders are never directly 
compared to those with depressive disorder only. Rather, both of these groups are compared to 
the reference group with neither depression nor anxiety. Another limitation is that these studies 
fail to account for depressive symptom severity, which is problematic because those with 
psychiatric comorbidities tend to have more severe symptoms (Kessler et al, 2005). 
Potential Mechanisms of the Anxiety-Cardiovascular Disease Relationship in Depressed 
Adults 
To my knowledge, no study has examined mechanisms that may underlie anxiety-CVD 
relationships in depressed adults. However, an emerging literature suggests that depressed adults 
with anxiety disorders or increased anxiety symptom severity may have more severe levels of 
CVD risk factors than depressed adults without anxiety. First, one study found that, in depressed 
adults, anxiety symptom severity was associated with higher total cholesterol levels (Fava et al., 
1996). Another study of middle-aged men found that adults with comorbid depressive and 
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anxiety disorders (OR = 1.85, 95% CI: 1.29-2.64), but not those with a depressive or anxiety 
disorder only, had a greater odds of having hypertension than adults without depressive or 
anxiety disorders (Carroll, Phillips, Gale, & Batty, 2010). A final study involving adults free of 
CVD examined associations of MDD (all cases) and MDD with comorbid generalized anxiety 
disorder with diminished high-frequency heart rate variability, a marker of parasympathetic 
nervous system function and an emerging CVD risk factor (Kemp, Quintana, Felmingham, 
Matthews, & Jelinek, 2012). Results of this study revealed that, while MDD was associated with 
lower high-frequency heart rate variability (a medium effect size), MDD with generalized 
anxiety disorder was associated with greater reductions in this factor (a large effect size; Kemp et 
al., 2012). Overall, this small literature suggests that anxiety may be associated with increased 
levels of CVD risk factors in depressed adults. Consequently, it is plausible that anxiety may 
increase CVD risk in depressed adults through these CVD risk factors. 
Hostility/Anger 
Hostility is a tendency to view the world in a negative and cynical fashion involving a 
negative attitude toward others, enmity, denigration, and ill will (Smith, Glazer, Ruiz, & Gallo, 
2004). Hostility is typically grouped with and accompanied by anger, a negative emotion ranging 
in intensity from irritation or annoyance to fury or rage that is usually elicited by perceived 
injustice (Torquato, de Souza, Iosifescu, & Fraguas, 2012). Moreover, hostility/anger can be 
expressed behaviorally as verbal and/or physical aggression (Smith et al., 2004). Consequently, 
as an affective trait, hostility/anger is the tendency to experience hostile attitudes, angry emotion, 
and/or aggression (Buss & Perry, 1992). Hostility/anger is typically measured as a continuous 
construct (Torquato et al., 2012), although an example of a dichotomous measure is the 
presence/absence of anger attacks (Cassiello‐Robbins & Barlow, 2016). In adults, hostility/anger 
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has high stability over time, as indicated by high test-retest correlations over one to three years (r 
range: 0.84-0.85), six years (r range: 0.61-0.66), and 30 years (r = 0.39; Barefoot, Dahlstrom, & 
Williams, 1983; Shekelle, Gale, Ostfeld, & Paul, 1983; Siegler et al., 1990; Stewart, Fitzgerald, 
& Kamarck, 2010). 
Overlap Between Hostility/Anger and Depression  
Like anxiety, hostility/anger overlaps with depression (Suls & Bunde, 2005). Correlations 
between self-report measures of depression and hostility/anger range from 0.22 to 0.44 (Mook, 
Van Der Ploeg, & Chr. Kleijn, 1990; Newman, Fuqua, Gray, & Simpson, 2006). Moreover, 
those with depressive disorders experience greater levels of hostility/anger compared to healthy 
controls (Cassiello‐Robbins & Barlow, 2016). To illustrate, recent evidence suggests that over 
50% of MDD patients experience clinical levels of overt anger/irritability (Judd, Schettler, 
Coryell, Akiskal, & Fiedorowicz, 2013). It has also been estimated that 33-44% of MDD patients 
experience anger attacks (Cassiello‐Robbins & Barlow, 2016). This common hostility/anger 
comorbidity in depressed adults is also associated with more severe, chronic, and complex 
depressive disorders (i.e., poorer prognosis, reduced psychosocial functioning, and a greater 
likelihood of comorbid psychiatric disorders; Judd et al., 2013). 
Hostility/Anger and Cardiovascular Disease in the General Population 
Evidence suggests that adults with higher levels of hostility/anger are at increased risk of 
developing CVD. A meta-analysis of 21 prospective studies revealed that, in initially healthy 
populations, hostility/anger was associated with a 19% increased risk of incident coronary heart 
disease (Chida & Steptoe, 2009). However, evidence for this relationship is less robust than for 
the depression-CVD and anxiety-CVD relationships, considering that the hostility/anger-CVD 
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relatioship fell short of significance after controlling for key covariates, such as smoking, 
physical activity, body mass index, and socioeconomic status (Chida & Steptoe, 2009). 
Nonetheless, some studies have found that the relationship between hostility/anger and incident 
CVD remains after including depression as a covariate (Boyle, Michalek, & Suarez, 2006; 
Kubzansky, Cole, Kawachi, Vokonas, & Sparrow, 2006; Newman et al., 2011), suggesting that 
the hostility/anger-CVD realtioship may be independent from depression. 
Associations between hostility/anger and incident CVD may, in part, be due to the 
relationship between hostility/anger and subclinical atherosclerosis. Consistent with this notion, 
prospective evidence suggests that anger (Räikkönen, Matthews, Sutton-Tyrrell, & Kuller, 
2004), as well as cynical distrust and anger control (Julkunen, Salonen, Kaplan, Chesney, & 
Salonen, 1994), promote the progression of carotid intima-media thickness. Additionally, those 
with higher levels of cynicism and those with higher levels of cynisim and anger (interaction 
effect) have greater progression of coronary artery calcification compared to those with lower 
levels of these characteristics (Low et al., 2011). Of note, in a study that accounted for anxiety 
and depression, neither hostility nor anger predicted 3-year progression of carotid intima-media 
thickness (Stewart et al., 2007). However, hostility/anger has consistently been found to relate to 
poorer endothelial function (Cooper et al., 2010; Harris et al., 2003; Lin et al., 2008; Schott et al., 
2009), and one of these studies found that this relationship persisted after accounting for anxiety 
and depression (Lin et al., 2008). In summary, the majority of literature indicates that 
hostility/anger is associated with greater subclinical atherosclerosis, and initial evidence suggests 
that this relationship may persist after controlling for other affective traits. 
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Hostility/Anger and Cardiovascular Disease in Depressed Adults 
Although the evidence suggests that hostility/anger increases CVD risk in the general 
population, to my knowledge, no studies have examined the relationship between hostility/anger 
and CVD outcomes in depressed adults. Consequently, it remains unknown whether depressed 
adults with hostility/anger are at greater CVD risk than depressed adults without hostility/anger. 
Potential Mechanisms of the Hostility/Anger-Cardiovasular Disease Relationship in 
Depressed Adults 
Given the preceding section, it is not surprising that no studies have investigated factors 
that may mediate hostility/anger-CVD risk relationships in depressed adults. Nonetheless, some 
candidate mediators can be identified by examining which CVD risk factors have been 
associated with hostility/anger in depressed adults. Compared to depressed adults without anger 
attacks, depressed adults with anger attacks have higher total cholesterol levels (Fava et al., 
1996; Fraguas et al., 2007) and more years of smoking (Fraguas et al., 2007). Two other studies 
found hostility to be associated with higher levels of inflammatory markers in adults with higher 
depressive symptoms but not in adults with lower depressive symptoms (Stewart, Janicki-
Deverts, Muldoon, & Kamarck, 2008; Suarez, 2003). This small literature suggests 
hostility/anger may be positively associated with some CVD risk factors in depressed adults. 
Consequently, it is plausible that hostility/anger may increase CVD risk in depressed adults 
through these CVD risk factors. 
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Low Trait Positive Affect 
Positive affect is the experience of pleasurable emotions such as joy, happiness, 
excitement, enthusiasm, and contentment (Tomkins et al., 1963). While these emotions can be 
transient and reflect current mood state, trait positive affect – the dispositional tendency to 
experience positive affect – is stable over time (Krueger, McGue, & Iacono, 2001; Watson, 
2002). For instance, Watson and Walker (1996) found that undergraduate students have 
relatively stable trait positive affect over six years (r = 0.42). Moreover, trait positive affect 
shows even stronger stability at later ages. For example, one study found high stability over 25 
years of follow-up from age 27 to 52 years (r = 0.61; Helson & Klohnen, 1998). The degree of 
trait positive affect is typically assessed as a continuous construct (Pressman & Cohen, 2005). 
Also of importance, evidence supports the independence of positive affect from negative affect, 
meaning that positive and negative affect are not merely bipolar extremes of the same continuum 
(Diener & Emmons, 1984; Headey, Kelley, & Wearing, 1993; Watson, Clark, & Tellegen, 
1988). To illustrate, a person who has a tendency to experience positive affect can also have a 
co-occurring tendency to experience various forms of negative affect (e.g., depression, anxiety, 
and hostility/anger). 
Overlap Between Low Trait Positive Affect and Depression  
Given that low pleasure and interest (i.e., anhedonia) is one core feature of depressive 
disorders (Pelizza & Ferrari, 2009), it is not surprising that positive affect and depression have 
been found to be negatively associated. To illustrate, a recent meta-analysis of 59 studies (pooled 
N = 24,503) found a significant cross-sectional correlation between trait positive affect and 
depression (r = -0.34; Khazanov & Ruscio, 2016). Of note, trait positive affect has been found to 
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related to measures of depressive symptom severity (e.g., Crawford & Henry, 2004; Headey et 
al., 1993; Watson, Clark, & Tellegen, 1988) and depressive disorders (e.g, Brown, Chorpita, & 
Barlow, 1998; Watson, Clark, Carey, 1988). Finally, evidence suggests that, compared to 
depressed adults with lower levels of anhedonia, those with higher levels of anhedonia have 
more severe depressive symptoms (Pelizza & Ferrari, 2009). 
Low Trait Positive Affect and Cardiovascular Disease in the General Population 
A relatively small literature has examined the relationship between trait positive affect 
and CVD risk. This literature suggests that, after adjustment for traditional CVD risk factors, 
trait positive affect is associated with a lower risk of incident stroke (Ostir, Markides, Peek, & 
Goodwin, 2001), coronary heart disease (Davidson, Mostofsky, & Whang, 2010; Hawkins et al., 
2014, Newman et al., 2011; Yanek et al., 2013), and composite cardiometabolic conditions (i.e., 
heart problems, hypertension, diabetes, or high cholesterol; Boehm, Chen, Williams, Ryff, & 
Kubzansky, 2016). Across these studies, trait positive affect was associated with a 12% to 26% 
reduced risk of the CVD outcomes. Two of these studies retained a positive affect-CVD 
relationship after controlling for depressive symptoms (Davidson et al., 2010; Newman et al., 
2011), and two others did not (Boehm et al., 2016; Hawkins et al., 2014). Of note, two additional 
studies did not detect a relationship between positive affect and incident CVD (Freak-Poli  
et al., 2015; Nabi et al., 2008). Nonetheless, the majority of this literature suggests that positive 
affect is associated with reduced CVD risk; however, it is unclear whether this relationship is 
independent of negative affective traits. 
Only one study has examined the relationship between positive affect and subclinical 
atherosclerosis (Kroenke, Seeman, Matthews, Adler, & Epel, 2012). Cross-sectional analyses 
revealed that, compared to people with higher positive affect, those with lower positive affect 
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(averaged over the course of a day by means of ecological momentary assessment) had an 86% 
increased likelihood of any coronary artery calcification and twice the likelihood of substantial 
coronary artery calcification, after adjustment for traditional CVD risk factors and depression. 
However, positive affect was unrelated to incident coronary artery calcification over the 5-year 
follow-up period. Of note, no studies have examined the relationship between trait positive affect 
and endothelial function.  
Low Trait Positive Affect and Cardiovascular Disease in Depressed Adults 
Because low trait positive affect is related to higher CVD risk in the general population, it 
is plausible that low positive affect may also elevate CVD risk in the depressed population. 
However, no studies have examined this relationship in depressed adults. As a result, it remains 
unknown whether depressed adults with lower trait positive affect are at greater CVD risk than 
depressed adults with higher trait positive afftect. 
Potential Mechanisms of the Low Trait Positive Affect-Cardiovascular Disease Relationship in 
Depressed Adults 
Although studies have yet to investigate factors that may mediate a trait positive affect-
CVD relationship in depressed adults, a few studies suggest that higher trait positive affect may 
protect against processes that promote CVD in those with negative affect (Fredrickson, 2001; 
Pressman & Cohen, 2005). For example, evidence suggests that higher positive affect may 
accelerate cardiovascular recovery from negative emotional arousal (Fredrickson & Levenson, 
1998; Tugade, & Fredrickson, 2004). This accelerated cardiovascular recovery may be protective 
against future cardiovascular risk (Chida & Steptoe, 2010). Additionally, one study found that 
positive mood was related to higher levels of natural killer cell activity, an immune marker that 
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is reduced in those with CVD (Camous, Pera, Solana, & Larbi, 2012), only among those who 
also experienced negative mood over the day (Valdimarsdottir & Bovbjerg, 1997). This small 
literature suggests that trait positive affect may reduce the degree of CVD risk factors in those 
with negative affect. 
The Present Study 
Although substantial evidence suggests that depressed adults are at increased risk of 
CVD, there may be subgroups in the depressed population at greater risk of developing CVD 
than others. Because other affective traits – i.e., anxiety, hostility/anger, and low trait positive 
affect – have been associated with increased CVD risk in the general population, depressed 
adults with higher levels of these co-occurring affective traits may be at greater risk of 
developing CVD. However, only the association between anxiety and CVD outcomes has been 
examined in depressed adults. To my knowledge, no study has simultaneously examined whether 
depression, anxiety, hostility/anger, and low trait positive affect are associated with CVD 
outcomes in depressed adults. 
In the studies examining the relationship between anxiety and CVD outcomes in 
depressed adults, none has controlled for depressive symptom severity. This is a key limitation 
for two reasons: (1) depressive symptom severity is positively correlated with other affective 
traits in depressed adults and (2) depressive symptom severity is positively related to increased 
CVD risk in depressed adults. Consequently, the observed associations between anxiety and 
CVD outcomes in depressed adults may be due to greater depressive symptom severity. 
One approach to disentangling these overlapping affective traits is to unpack them into 
mutually exclusive shared and unique components (see Figure 1) and examine how these 
components relate to CVD outcomes (see Figure 2). Some previous research suggests that unique 
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anxiety (Batelaan et al., 2016), unique hostility/anger (Boyle et al., 2006; Kubzansky et al., 2006; 
Newman et al., 2011; Lin et al., 2008), and unique trait positive affect (Davidson et al., 2010; 
Newman et al., 2011; Kroenke et al., 2012) predict future CVD in the general population. In 
these investigations, depressive symptom severity was included as a covariate in models 
examining the relationship between the affective traits and CVD outcomes. Additionally, two 
previous studies found that the shared variance between depression, anxiety, and hostility/anger 
predicted incident CVD in initially healthy samples (Boyle et al., 2006; Kubzansky et al., 2006). 
However, no study has examined the shared and unique components of these affective traits in 
relation to CVD outcomes in depressed adults. 
Finally, the evidence reviewed suggests that anxiety and hostility/anger are positively 
related to various CVD risk factors in depressed adults and that positive affect may reduce the 
degree of CVD risk factors in those with negative affect. Thus, it is plausible that these CVD risk 
factors partially mediate affective trait-CVD relationships in depressed adults. However, no 
study has examined candidate mediators of affective trait-CVD associations in depressed adults. 
The aims of the present study are designed to begin to address the aforementioned gaps in 
knowledge. The three aims are as follows: 
1) To examine which affective traits – depression (depressive symptom severity), 
anxiety (anxiety symptom severity), hostility/anger, and low trait positive affect – 
are associated with endothelial function in depressed adults 
2) To investigate which components of affective traits are associated with 
endothelial function in depressed adults 
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a. To examine which depression and anxiety components (shared variance, 
unique depression variance, and unique anxiety variance) are associated 
with endothelial function 
b. To examine which depression and hostility/anger components (shared 
variance, unique depression variance, and unique hostility/anger variance) 
are associated with endothelial function 
c. To examine which depression and trait positive affect components (shared 
variance, unique depression variance, and unique positive affect) are 
associated with endothelial function 
3) To explore traditional CVD risk factor status as a candidate mediator of any 
significant relationships observed in the Aim 2 models 
To achieve these aims, I combined pre-treatment, cross-sectional data from three 
randomized controlled trials involving primary care patients with clinically significant depressive 
symptoms. All three trials were designed to examine whether a depression treatment improved 
endothelial function as indicated by brachial artery FMD. These data provide a good opportunity 
to achieve the present study’s aims because the pre-treatment assessments for all three trials 
included measures of the affective traits of interest, endothelial function, and traditional CVD 
risk factors. Based on the literature reviewed, I hypothesized (1) that all of the affective traits 
will be negatively associated with endothelial function, (2) that both the shared and unique 
components of each affective trait will be negatively related to endothelial function, and (3) that 
traditional CVD risk status would partially mediate observed associations in the Aim 2 models. 
To test this hypothesis, I utilized a composite measure of traditional CVD risk status: 10-year 
Framingham risk score (D’Agostino et al., 2008). This risk score uses an algorithm to combine 
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individual traditional CVD risk factors (age, sex, systolic blood pressure, BMI, taking an 
antihypertensive medication, diabetes diagnosis, and current smoking status) into a single 
estimate of traditional CVD risk status that is expressed as the estimated percentage (0-100%) of 
10-year CVD onset in adults initially free of CVD (D’Agostino et al., 2008; Greenland et al., 
2010). 
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METHODS 
Study Sample 
To create the study sample, I combined pre-treatment, cross-sectional data from three 
randomized controlled trials involving depressed primary care patients from Eskenazi Health: 
Beating the Blues for Your Heart Trial (BtB-Heart Trial; n = 29), Targeting Systemic 
Inflammation to Concurrently Treat Late-Life Depression and Reduce Coronary Artery Disease 
Risk (INFLAMED Trial; n = 17), and Modernized Collaborative Care to Reduce the Excess 
CVD Risk of Older Depressed Patients (eIMPACT Trial; n = 94). Eskenazi Health is the second 
largest safety net healthcare system in the U.S providing care to ≈ 20% of the Indianapolis 
population. Eskenazi Health patients are mostly underinsured/uninsured (90%) and 
approximately half are non-Hispanic Black. From the combined sample of 142 adults, I excluded 
three participants with missing values for endothelial function (n = 1 from BtB-Heart, n = 1 from 
INFLAMED, and n = 1 from eIMPACT) and one participant from BtB-Heart who was missing 
all questionnaire data. All 138 remaining participants had complete data across demographic 
factors and FMD. There was <1% missingness across the affective traits data, which was 
accounted for when parceling the questionnaire items (see Data Analyses). There were also five 
missing values (3.6% missingness) for the 10-year Framingham risk score, which was accounted 
for by utilizing full information maximum likelihood (FIML) estimation in the analysis that 
utilized this variable. Thus, the present study’s sample consisted of 138 depressed primary care 
patients.  
The recruitment approaches and inclusion/exclusion criteria were similar across the three 
trials. First, the Eskenazi Health electronic medical record was searched in accordance with 
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HIPAA to generate lists of potentially eligible patients. Next, research assistants from ResNet, 
Indiana University’s primary care practice-based research network, obtained permission to 
approach these patients. Finally, ResNet assistants conducted in-clinic and telephone screening 
of identified patients to determine eligibility. For eligible and interested patients, ResNet 
assistants obtained informed consent and authorization. 
Eligible primary care patients were those with no history of clinical CVD (coronary 
artery disease, cerebrovascular disease, acute MI, percutaneous coronary intervention, or 
coronary artery bypass graft) and with clinically significant depressive symptoms. Clinically 
significant depressive symptoms were defined as a score ≥ 10 on the Patient Health 
Questionnaire-9 (PHQ-9), a cutoff which has a sensitivity of 88% and a specificity of 88% for 
major depressive disorder (Kroenke, Spitzer, & Williams, 2001). Complete inclusion/exclusion 
criteria for each of these trials is presented in Appendix A. 
Measures 
Independent Variables 
The questionnaires used to assess the independent variables are presented in Appendix B. 
Descriptions of these questionnaires are provided below. 
Depressive Symptom Severity 
Depressive symptom severity was assessed with the 20 depression items from the 
Symptom Checklist-90 (SCL-20; Derogatis, Lipman, & Covi, 1973). For each item on the SCL-
20, participants indicated how often they experienced various depressive symptoms during the 
last week, with response options of not at all (0), a little bit (1), moderately (2), quite a bit 
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(3), and extremely (4). The average score across all items is calculated so that the SCL-20 total 
score ranges from 0 to 4, with higher scores indicating greater depressive symptom severity. The 
SCL-20 has demonstrated good internal consistency (Cronbach’s α = .86) and test-retest 
reliability (r over one week = .81; Derogatis, Lipman, Rickels, Uhlenhuth, & Covi, 1974) and is 
strongly related to other validated measures of depressive symptom severity (Dinning & Evans, 
1977). 
Anxiety Symptom Severity 
The Generalized Anxiety Disorder-7 (GAD-7), a seven-item questionnaire, was utilized 
to assess anxiety symptom severity (Spitzer, Kroenke, Williams, & Löwe, 2006). For each item 
on the GAD-7, participants were asked to indicate the degree to which they had been bothered by 
the selected symptom during the last two weeks, with response options of not at all (0), several 
days (1), more than half the days (2), and nearly every day (3). Scores are summed across all 
items so that the GAD-7 total score ranges from 0 to 21, with higher scores indicating greater 
anxiety symptom severity. The internal consistency of the GAD-7 is excellent (Cronbach’s α = 
0.92), and its test-retest reliability is good (r over one week = 0.83; Spitzer et al., 2006). It also 
demonstrates good convergent validity, as indicated by strong correlations with other self-
reported measures of anxiety symptom severity (Spitzer et al., 2006). 
Hostility/Anger 
Hostility/anger was assessed with 29 items from the Buss-Perry Aggression 
Questionnaire (BPAQ; Buss & Perry, 1992). For each item, participants indicated how 
uncharacteristic or characteristic statements are in describing them, with response options of 
extremely uncharacteristic (1), somewhat uncharacteristic (2), neither uncharacteristic nor 
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characteristic (3), somewhat characteristic (4), and extremely characteristic (5). The BPAQ 
consists of the following four subscales: hostility, anger, verbal aggression, and physical 
aggression. Scores across all items are summed so that the BPAQ total score ranges from 29 to 
145, with higher scores indicating greater hostility/anger. The BPAQ has demonstrated adequate 
to good internal consistency for the subscales (Cronbach’s α = 0.72-0.85) and the total score 
(Cronbach’s α = 0.89; Buss & Perry, 1992). It has also demonstrated adequate test-retest 
reliability over a 9-week period for each subscale (r = 0.72-0.80) and the total score (r = 0.80; 
Buss & Perry, 1992). Convergent validity of the BPAQ has been demonstrated by moderate 
correlations of the total score with measures of similar personality traits, such as assertiveness, 
competitiveness, and impulsivity (Buss & Perry, 1992). 
Trait Positive Affect 
Trait positive affect was assessed using the positive affect (PA) subscale of the Positive 
and Negative Affect Schedule (PANAS; Watson, Clark, & Tellegen, 1988). Participants were 
asked to report the extent to which they have experienced ten positive emotions, on average, on a 
5-point scale, with response responses of very slightly or not at all (1), a little (2), moderately 
(3), quite a bit (4), or extremely (5). Scores are summed across all items so that the PANAS-PA 
total score ranges from 10 to 50, with higher scores indicating greater trait positive affect. The 
PANAS-PA has demonstrated good internal consistency (Cronbach’s α = 0.86-0.90) and is 
relatively stable over an 8-week period (r = 0.47-0.68; Watson & Clark, 1994). The PANAS-PA 
also relates to peer-reports of trait positive affect and demonstrated good convergent validity 
with similar constructs, such as vigor (Watson & Clark, 1994). 
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Dependent Variable 
Endothelial Function 
Endothelial function was assessed by brachial artery FMD. FMD is a noninvasive 
technique that uses high-resolution ultrasound to measure changes in brachial artery diameter in 
response to an induction of increased blood flow (Celermajer et al., 1992). In the assessment of 
FMD, a blood pressure cuff is inflated around the forearm to occlude the brachial artery for 
several minutes (Celermajer et al., 1992). Then, the cuff is rapidly released to induce increased 
blood flow, which increases sheer stress on the vessel wall (Celermajer et al., 1992). High-
resolution ultrasound is used to measure the degree to which the brachial artery dilates in 
response to this increase in sheer stress (Thurston et al., 2013). A healthy artery dilates 
substantially in response to this stimulus, whereas a compromised artery dilates minimally or 
may even constrict (Matthews, 2005). Because this response is mediated by the endothelium, a 
lesser degree of dilation is indicative of greater endothelial dysfunction (Hadi, Carr, & Suwaidi, 
2005; Thurston et al., 2013).  
In all three trials, patients underwent FMD assessments in accordance with consensus 
guidelines (Corretti et al., 2002). The vascular ultrasonographer who completed the FMD 
assessments and the physician who scored the ultrasound images had completed certified training 
through the University of Wisconsin Brachial Artery Reactivity Testing Symposium. To obtain 
the brachial artery images, a GE Logiq E ultrasound system with AccessPoint 2011 software was 
used. After a 10-minute supine rest, high-resolution baseline images of the brachial artery were 
obtained from three consecutive cardiac cycles. Next, the forearm cuff was inflated to 250 
mmHg for five minutes before being rapidly deflated. At 60 and 90 seconds post deflation, 
images from three consecutive cardiac cycles were acquired. Fifteen minutes post deflation, 
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baseline images were again obtained. Brachial diameters were measured at peak R wave. FMD 
values were computed as the percent change in diameter at 60 and 90 seconds post deflation, and 
the larger of the two values was used. 
Covariates 
Given their potential associations with both the affective traits and endothelial function, 
demographic factors (age [years], sex [0 = male, 1 = female], race/ethnicity [0 = not non-
Hispanic Black, 1 = non-Hispanic Black], and education [0 = high school graduate/GED or 
equivalent or more than high school, 1 = less than high school) and baseline arterial diameter 
(cm) were included as covariates. Participants were asked to indicate their age, sex, 
race/ethnicity, and highest education level completed. Responses were aggregated into two 
categories for race/ethnicity and education to effectively merge the slightly differing response 
options for these factors across the three trails. Finally, baseline arterial diameter was assessed 
during the FMD assessment. 
Traditional Cardiovascular Disease Risk Status Mediator 
Many traditional CVD risk factors are candidate mediators of the hypothesized affective 
trait-endothelial function relationships. Framingham risk scores use algorithms to combine 
traditional CVD risk factors into a single quantitative estimate of CVD risk expressed as a 
percentage (Greenland et al., 2010). I chose to calculate the 10-Year Framingham risk score, 
which estimates risk of CVD onset (coronary death, MI, coronary insufficiency, angina, ischemic 
stroke, hemorrhagic stroke, transient ischemic attack, peripheral artery disease, and heart failure) 
over the next 10 years in adults initially free of CVD (D’Agostino et al., 2008). Values range 
from 0 to 100%, and values greater than 20% are indicative of high CVD risk (Greenland et al., 
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2010). The Framingham algorithm incorporates the following traditional CVD risk factors that 
were assessed across the three trials: age, sex, systolic blood pressure, BMI, taking an 
antihypertensive medication, diabetes diagnosis, and current smoking status. Three seated blood 
pressure readings were obtained by a research nurse using a standard sphygmomanometer, and 
systolic blood pressure was computed as the average of the last two readings. BMI was 
computed as measured weight (kg) divided by measured height (m) squared. Current smoking 
status (yes, no) was determined through self-report; participants who reported smoking at least 
100 cigarettes during their lifetime and indicated that they now smoke cigarettes every day or 
some days were classified as current smokers (Nelson et al., 2000). Antihypertensive medication 
(yes, no) was assessed by asking participants to indicate whether or not they were currently 
taking medication for high blood pressure. Diabetes diagnosis (yes, no) was assessed by 
querying participants whether or not they had ever been diagnosed with diabetes by a health 
professional. 
Procedure 
As soon as was feasible after enrollment, participants attended a 3-hour pre-treatment 
visit at the Clinical Research Center of the Indiana Clinical and Translational Sciences Institute. 
Participants were instructed to fast and to avoid tobacco and exercise for eight hours before their 
visit. Participants had their height, weight, and blood pressure measured; completed self-report 
scales via a website on a secure computer; and underwent the FMD assessment and a blood 
draw. For two of the three trials (BtB-Heart and eIMPACT), participants’ heart rate was also 
monitored for approximately five minutes while resting supine to derive a measure of high-
frequency heart rate variability. To end the pre-treatment visits, participants were randomized to 
one of two groups, and additional study visits were scheduled. 
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Data Analyses 
Parceling Affective Measures 
Items of each affective measure were randomly aggregated to create three parcels for 
each affective trait (Parceling approach recommended by Matsunaga, 2008). For example, items 
on the SCL-20 were randomly aggregated to create three Depression parcels: SCL-20 Parcel 1, 
SCL-20 Parcel 2, and SCL-20 Parcel 3. This process was repeated for the GAD-7 items, BPAQ 
items, and PANAS-PA items to create three parcels for Anxiety, Hostility/Anger, and Positive 
Affect, respectively. There was <1% missingness across all affective traits data. After parceling, 
within-parcel missingness ranged from 0.2% to 1.3%. Examination of individual cases revealed 
two cases with one instance of within-parcel missingness >50% (one case with 6 of the 10 values 
missing for the BPAQ Parcel 1 items and another case with 2 of the 3 values missing for the 
PANAS-PA Parcel 2 items). Given the low rates of within-parcel missingness and the few 
individual cases with instances of >50% within-parcel missingness, I utilized within-parcel mean 
imputation to account for these missing values. The resulting affective trait parcels with 
complete data were utilized in the Aim 1-3 models. 
Data Cleaning 
Initial data cleaning procedures assessed for missing data, outliers, and normality for each 
variable using SPSS statistical software (Version 20). 
Prior to any imputation or FIML procedures to account for missing data, I checked for 
systematic missingness in the dataset by age, sex, race/ethnicity, and education. To complete this 
check, I created a dichotomous missingness variable (0 = not missing, 1 = missing) for the 12 
affective trait parcels, FMD, baseline arterial diameter, 10-year Framingham risk score, and 
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individual CVD risk factors included in this risk score. Then, I conducted chi-square tests for 
sex, race/ethnicity, and education and independent sample t-tests for age with each missingness 
variable. This check revealed only one relationship: mean age was significantly younger for 
those with missing data on the BPAQ Parcel 1 (M = 48 years, SD = 3.1) compared to those with 
no missing data (M = 57 years, SD = 6.9; t(136) = 3.69, p < 0.001). It is likely that the detected 
relationship is a type 1 error because (a) 80 analyses were performed to check for systematic 
missingness and (b) age did not relate to missingness on the other BPAQ parcels. Accordingly, 
analytic procedures proceeded as planned. 
To identify out-of-range values, I examined variable frequencies. This examination 
revealed all values to be within the plausible range. To identify outliers, I examined all 
continuous variables for z score values ≤ -3.3 or ≥ 3.3. Amongst all variables in the dataset, only 
two outliers were detected (z scores = 3.4 and 3.6), which were for the Framingham Risk Score 
variable. These two outliers were not altered or deleted for three reasons: (1) these cases did not 
result in non-normal distributions, (2) some z scores ≤ -3.3 or ≥ 3.3 are expected with larger 
samples, and (3) these cases are likely legitimate cases of the sample population (Tabachnick & 
Fidell, 2001). 
To determine normality, I examined variables for excessive skew (≤ -3 or ≥ 3) and 
kurtosis (≤ -10 or ≥ 10) (Kline, 1998). Because no variables exhibited excessive skew or 
kurtosis, deviations from normality in this dataset were insubstantial. 
Computing Correlations 
Correlation analyses were completed using SPSS statistical software (Version 20). I 
conducted two sets of correlational analyses: bivariate correlations and partial correlations after 
controlling for the covariates (age, sex, race/ethnicity, education, and baseline arterial diameter). 
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These correlational analyses were conducted (a) between all affective trait measures to elucidate 
the degree of overlap among these factors, (b) between each affective trait measure and the 10-
year Framingham risk score to examine associations of affective traits and traditional CVD risk 
status, (c) between each affective trait measure and FMD to examine the associations of affective 
traits with endothelial function, and (d) between the 10-year Framingham risk score and FMD to 
examine the association between traditional CVD risk status and endothelial function. 
Primary Analyses  
For all primary analyses, I utilized LISREL 8.8 software (Jöreskog & Sörbom, 2008) to 
conduct structural equation modeling (SEM). These SEM analyses included measurement 
models that utilized confirmatory factor analysis (CFA) – a statistical, hypothesis-driven 
approach that examines covariation among observed indicator variables to gather information on 
a smaller number of latent variables (Brown, 2006). This approach is preferable to exploratory 
factor analysis because it allows the researcher to specify and test a model based on empirical 
and/or theoretical literature (Brown, 2006). CFA measurement models were followed by 
construction of structural models, which examine directional relationships between latent 
variables (Schreiber, Nora, Stage, Barlow, & King, 2006). I utilized maximum likelihood 
estimation for the Aim 1 and 2 models and FIML estimation for the Aim 3 model to account for 
five missing Framingham risk score values. To assess model fit, I examined absolute (model χ2 
statistic and standardized root mean square residual; SRMR), parsimonious (root mean square of 
approximation; RMSEA), and incremental (comparative fit index; CFI) fit indices (Hu & 
Bentler, 1999). Values for these fit indices were evaluated using the following common 
recommendations for acceptable model fit: < .08 for SRMR, < .06 for RMSEA, and > .95 for 
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CFI (Hu & Bentler, 1999) as well as a low model χ2 statistic relative to degrees of freedom (χ2/df 
< 3:1 ratio) with an insignificant p value (p > 0.05; Kline, 2005). 
Latent variables were constructed from the observed indicator variables. The three 
parcels for each affective trait measure served as indicators loading onto their corresponding 
affective trait latent variables: Depression, Anxiety, Hostility/Anger, and Positive Affect. In the 
present study, a parceling approach is preferable to using all of the individual questionnaire items 
as indicators because model fit can be adversely affected by large sets of indicators (Little, 
Cunningham, Shahar, & Widaman, 2002). FMD value served as the single indicator loading onto 
the Endothelial Function latent variable, and the 10-year Framingham risk score served as the 
single indicator loading onto Traditional CVD Risk Status latent variable. To achieve 
identification, one of the loadings for each set of three parcels was set to one, the error for FMD 
was set to zero, and the error for the Framingham risk score was set to zero (Hayduk & Littvav, 
2012). 
All analyses utilizing the FMD indicator accounted for age, sex, race/ethnicity, education, 
and baseline arterial diameter by residualizing the FMD indicator for these potential confounders 
prior to constructing the Endothelial Function latent variable. This residualizing approach was 
utilized because including these variables in models as covariates would have result in a ratio of 
participants to estimated parameters below the acceptable lower limit of 5:1 (Kline, 2005). To 
illustrate, after utilizing this residualizing approach, the most complex model (see Figure 7) had a 
ratio of participants (138) to estimated parameters (21) of 6.6:1. 
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RESULTS 
Characteristics of Participants 
Descriptive statistics for the total sample are presented in Table 1. Participants’ ages 
ranged from 40-74 years, with a mean of 56. The sample was almost 70% women, nearly 40% 
identified as non-Hispanic Black, and 18% had less than a high school education. Traditional 
CVD risk factors were highly prevalent, as 32% reported a diabetes diagnosis, 64% had a BMI in 
the obese range (BMI ≥ 30 kg/m2), 59% reported taking antihypertensive medication, 34% had a 
systolic blood pressure indicative of hypertension (≥ 140 mmHg), and 43% reported current 
smoking. The high CVD risk factor burden resulted in mean 10-year Framingham risk score of 
23%, which falls in the high CVD risk range (> 20%). Regarding the affective trait measures, the 
mean SCL-20 score (1.8) was comparable to that observed in other depressed primary care 
samples (Katon et al., 1996; Williams, Stellato, Cornell, & Barrett, 2004). The mean GAD-7 
score (10.4) fell in the moderate anxiety symptom severity range (Spitzer e al., 2006). As was 
expected, the mean BPAQ score (75.0) was higher and the mean PANAS score (27.2) was lower 
than that observed in samples of the general adult population (Hawkins, Stewart, Fitzgerald, & 
Kim, 2011; Suarez & Krishnan, 2006; Watson & Clark, 1994). 
Descriptive statistics for each of the three subsamples are also presented in Table 1. 
Although the participant characteristics were generally similar across the three trials, ANOVAs 
and chi-square tests revealed some significant differences. Specifically, the BtB-Heart subsample 
was younger than the eIMPACT and INFLAMED subsamples, likely due to differences in age 
inclusion criterion (see Appendix A). The eIMPACT subsample was comprised of more women 
than the BtB-Heart subsample, even though there were no inclusion/exclusion criteria regarding 
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sex. Concerning traditional CVD risk factors, eIMPACT subsample had a higher diabetes 
prevalence than the BtB-Heart subsamples, had higher systolic blood pressure than the 
INFLAMED subsample, had higher antihypertensive medication use than the BtB-Heart and 
INFLAMED subsamples, and had a higher 10-year Framingham risk score than the BtB-Heart 
subsample. These differences are likely due to eIMPACT being the only trial with elevated CVD 
risk as an inclusion criterion. No other differences were detected between subsamples across all 
remaining variables. 
Correlations 
Both bivariate and partial correlations revealed depression (SCL-20) was positively 
related to anxiety (GAD-7; shared variance of 49% [bivariate] and 52% [partial]) and negatively 
related to positive affect (PANAS-PA; shared variance of 10% [bivariate] and 8% [partial]) but 
was unrelated to hostility/anger (BPAQ; shared variance of 1% [bivariate] and 3% [partial]) (see 
Table 2). Bivariate correlations between affective trait measures and FMD revealed no 
significant relationships. However, a significant and negative partial correlation between 
hostility/anger (BPAQ) and FMD was detected (p = 0.02). All other partial correlations between 
affective trait measures and FMD were not significant. In addition, both the bivariate and partial 
correlations between 10-year Framingham risk score and FMD were not significant. 
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Primary Results 
Aim 1 Results 
Measurement models were not constructed for Aim 1 hypotheses because they would 
have been saturated (i.e., the number of estimated parameters would be equivalent to the number 
of data points), which prevents estimation of fit indices. 
To examine which affective traits are associated with endothelial function (Aim 1), four 
structural models were constructed, one for each affective trait (see Models 1-4 in Figure 3). 
Each model consisted of one latent variable for the affective trait and one for Endothelial 
Function. All analyses had a directional path specified from the affective trait to Endothelial 
Function. In general, all four models showed acceptable fit to the data (see Table 3 for fit 
indices). The one exception was for the RMSEA score (.07) for Model 4, which fell slightly 
above the recommended cut-off value (<.06). However, this fit statistic is more likely a function 
of a small df (2) and low N (138), the combination of which often results in artificially large 
RMSEA values that falsely indicate a poor model fit (Kenny, Kaniskan, & McCoach, 2015). For 
this reason, Kenny and collegues (2015) advised against computing RMSEA for low df models 
that lack large samples. 
As is shown in Figure 3, the paths from Depression, Anxiety, and Positive Affect to 
Endothelial Function were all not significant (p = .19, .87, and .71, respectively), and the 
standardized coefficients were small, ranging from -.03 to .11. In contrast, the path from 
Hostility/Anger to Endothelial Function was significant (p = .04). The standardized coefficient 
indicated that every 1-standard deviation (SD) increase in Hostility/Anger was associated with a 
.18-SD decrease in Endothelial Function. 
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Aim 2 Results 
To evaluate model fit for pairs of affective traits, measurement models were constructed, 
two sets for each affective trait pair. In the first set, both affective traits were specified as first-
order latent variables freed to correlate. As is detailed in Table 3, Models 5.1 (Depression, 
Anxiety) and 7.1 (Depression, Positive Affect) showed acceptable fit to the data; however, 
Model 6.1a (Depression, Hostility/Anger) showed poor fit. Modification indices suggested that 
the error of two pairs of indicators be correlated to improve model fit: SCL-20 Parcel 2 error 
correlated with BPAQ Parcel 2 error and SCL-20 Parcel 3 error correlated with BPAQ Parcel 3. I 
correlated these errors in Model 6.1b, which resulted in generally acceptable fit to the data (see 
Table 3). The one exception was for the RMSEA score (.07) that fell slightly above the 
recommended cut-off value (<.06), which may be a function of a small df (6) and low N (138) 
(Kenny et al, 2015). 
In the second set of measurement models, a second-order latent variable (Shared 
Variance), representing overlapping aspects of each affective trait pair (Brown, 2006), was added 
to Models 5.1, 6.1b, and 7.1 to construct Models 5.2, 6.2, and 7.2. As is shown in Table 3, all of 
the models with the Shared Variance latent variable showed poor fit to the data. For each poor 
fitting model, suggested modifications indices were too numerous to be feasibly implemented. 
Altogether, these results do not support modeling the Shared Variance between each affective 
trait pair.  
Therefore, I proceeded to investigate which unique components of affective traits are 
associated with endothelial function in depressed adults (Aim 2) by constructing three structural 
models (see Figures 4, 5, and 6). Of note, these models (Models 8, 9, and 10) build upon the first 
set of measurement models that achieved acceptable fit (Models 5.1, 6.1b, and 7.1) by adding 
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Endothelial Function as a latent variable and a directional path from each affective trait to 
Endothelial Function. All three of these Aim 2 Structural Models showed acceptable fit to the 
data (see Table 3). 
The paths from Depression and Anxiety (p =.12 and .31; Figure 4) and from Depression 
and Positive Affect (p =.21 and .92; Figure 6) to Endothelial Function were all not significant. 
Similarly, in Figure 5, the path from Depression to Endothelial Function was again not 
significant (p = .08); however, the path from Hostility/Anger to Endothelial Function was 
significant (p = .02). The standardized coefficient indicated that every 1-SD increase in 
Hostility/Anger was associated with a .22-SD decrease in Endothelial Function. Importandly, 
while the standardized coefficient between Positive Affect and Endothelial Function was small 
(.01; Figure 6), other nonsignificant coefficients were of notable magnitude, including paths 
between Depression and Endothelial Function (standardized coefficients of .22 and .15; Figures 
4 and 5, respectively), and the path between Anxiety and Endothelial Function (standardized 
coefficients = .14; Figure 4). 
Aim 3 Results 
To explore Traditional CVD Risk Status as a candidate mediator of the significant path 
from Hostility/Anger to Endothelial Function, I constructed Model 11 presented in Figure 7. This 
model added the Traditional CVD Risk Status latent variable and directional paths from 
Hostility/Anger to this variable and from this variable to Endothelial Function to Model 9. Model 
11 showed acceptable fit to the data (see Table 3). As seen in Figure 7, the path from 
Hostility/Anger to Endothelial Function remained significant (p = .02). However, the 
Hostility/Anger to Traditional CVD Risk Status path (p = .56) and Traditional CVD Risk Status 
to Endothelial Function path (p = .88) were both not significant. Not surprisingly, the indirect 
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effect of Hostility/Anger to Endothelial Function through Traditional CVD Risk Status was also 
not significant (standardized coefficient for the indirect effect = .00; p = .89). Consequently, the 
relationship between the unique components of hostility/anger and endothelial function were not 
partially explained by traditional CVD risk status. 
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DISCUSSION 
Summary of Findings and Fit with Prior Literature 
The present study sought to examine, among depressed adults, (1) whether depression, 
anxiety, hostility/anger, and low trait positive affect are associated with endothelial function, (2) 
whether the shared and unique components of these affective traits are related to endothelial 
function, and (3) whether traditional CVD risk factor status mediates these affective trait-
endothelial function associations. To achieve these aims, three hypotheses were tested.  
My first hypothesis that all of the affective traits would be negatively associated with 
endothelial function was, for the most part, unsupported. The associations of depression, anxiety, 
and positive affect with endothelial function were all not significant and small in magnitude. One 
exception to these null results was hostility/anger, which had a significant negative association 
with endothelial function. This finding is in line with a small but consistent literature indicating 
that hostility/anger is related to poorer endothelial function in the general population (Cooper et 
al., 2010; Harris et al, 2003; Lin et al., 2008; Schott et al, 2009). My results extend this 
relationship to depressed adults.  
While this is the first study to examine the relationship between depressive symptom 
severity and endothelial function in depressed adults, my null result conflicts with the majority of 
previous literature supporting an inverse association between depression and endothelial function 
in the general population (Cooper et al., 2011; Wu, Sun, Wang, & Ma, 2018). Consequently, our 
sample comprised of only depressed adults may account for the lack of relationship between 
depression and endothelial function. Although utilizing a depressed sample did not restrict the 
range of depression scores (M = 1.8, SD = 0.8, observed range: 0.0 to 3.7, possible range: 0.0-
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4.0), only a small proportion of my sample had low depression scores (only 4 participants had 
SCL-20 scores ≤ 0.5; Dietrich et al., 2004). This clustering of depression scores away from low 
values could prevent detection of a relationship previously observed in general population 
samples. Given the significant correlations of depression with anxiety and positive affect (see 
Table 2), my depressed sample may have similarly influenced, to a lesser degree, the 
distributions of these affective traits and their associations with endothelial function. Indeed, I 
observed few mild anxiety scores (14 participants with GAD-7 scores < 5; Spitzer e al., 2006) 
and a higher mean anxiety score (10.4) than that observed in general population samples (4.9; 
Spitzer e al., 2006). In addition, the mean PANAS score (27.2) was lower than that observed in 
samples of the general adult population (36.0; Watson & Clark, 1994). 
The null result for anxiety adds to a small and inconsistent literature on the anxiety-
endothelial function relationship in generally healthy adults. My finding is consistent with two 
previous studies not detecting an association (Routledge et al., 2017; Schott et al., 2009), which 
conflict with three other investigations reporting that anxiety symptom severity is associated with 
poorer endothelial function (Cooper et al., 2010; Harris et al., 2003; Narita et al., 2007). 
However, to my knowledge, this is the first study to examine this relationship in depressed 
adults. Moreover, because previous studies suggest that some types of anxiety disorders (e.g., 
panic disorder), but not others (e.g., generalized anxiety disorder and social phobia), are related 
to incident CVD in depressed adults (Gomez-Caminero et al., 2005; Scherrer et al., 2010), it may 
be that the relationship between anxiety and endothelial function in depressed adults also varies 
by anxiety type. Given that the aforementioned studies examined the relationship between 
general anxiety measures and endothelial function, moderation by anxiety type remains a 
potential explanation for the mixed literature. 
  44 
 
Finally, although this is the first study to examine the positive affect-endothelial function 
relationship in any population, my null result adds to a small mixed literature on the relationship 
between positive affect and CVD outcomes in general. My finding is consistent with the smaller 
segment of this literature that did not find positive affect to be associated with coronary artery 
calcification (Kroenke et al., 2012) and incident CVD (Freak-Poli et al., 2015; Nabi et al., 2008). 
However, given that the majority of previous studies have found positive affect to be negatively 
related to CVD outcomes (Boehm et al., 2016; Davidson et al., 2010; Hawkins et al., 2014; 
Kroenke et al., 2012; Newman et al., 2011; Ostir et al., 2001; Yanek et al., 2013), it is more 
likely that positive affect is not associated with CVD outcomes in depressed adults in particular, 
although further research is needed to evaluate this possibility. 
My second hypothesis that both the shared and unique components of each affective trait 
would be negatively related to endothelial function was also generally unsupported. First, I was 
unable to model the shared variance between each affective trait pair because all models failed to 
achieve acceptable model fit when the second-order latent variable (Shared Variance) was added 
to them. This outcome is inconsistent with two previous studies that successfully examined the 
shared variance between affective traits in relation to CVD outcomes (Boyle et al., 2006; 
Kubzansky et al., 2006). However, those studies did not evaluate model fit, utilized an 
exploratory rather than a confirmatory factor analytic approach to create their shared variance 
variables, examined the shared variance between three and four affective traits rather than two 
traits, and examined general population samples rather than a depressed sample, all of which 
may have contributed to the differing modeling outcomes. 
When I proceeded to investigate which unique components of affective trait pairs are 
associated with endothelial function in depressed adults, the pattern of results was identical to 
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that from the Hypothesis 1 models. Specifically, only the unique components of hostility/anger 
were associated with endothelial function, and this relationship was in the negative direction. 
Although a previous study did not detect a relationship between hostility and 3-year progression 
of carotid intima-media thickness after controlling for depression and anxiety (Stewart et al., 
2007), the detected relationship is consistent with most of the previous literature, which has 
found that hostility/anger is associated with worse clinical CVD outcomes (Boyle et al., 2006; 
Kubzansky et al., 2006; Newman et al., 2011) and poorer endothelial function (Lin et al., 2008) 
after including depression as a covariate. Importantly, my results extend these findings to the 
depressed population. Moreover, the magnitude of the observed unique hostility/anger-
endothelial function relationship (r = -.22 using the Peterson and Brown [2005] conversion 
method) is comparable to (a) the magnitude of this relationship detected in the one previous 
study in the general population (i.e., r = -.23 between hostility/anger and endothelial function 
after accounting for depression and anxiety; Lin et al., 2008) and (b) the magnitude of traditional 
CVD risk factor-endothelial function relationships detected in previous studies, such as that for 
cigarette smoking (r = -0.20), older age (r = -0.20), and overall CVD risk factor status (r = -0.30) 
(Celermajer, Sorensen, Bull, Robinson, & Deanfield, 1994). The latter set of results suggests that 
the detected hostility/anger-endothelial function relationship may be clinically meaningful. 
The Hypothesis 2 null results warrant careful consideration. For instance, the magnitude 
of the detected relationship between unique hostility/anger and endothelial function 
(standardized coefficient = -.22; p =.02) was similar to that of the undetected relationship 
between unique depression and endothelial function when modeled with anxiety (standardized 
coefficient = .22; p = .12) or hostility/anger (standardized coefficient = .15; p = .08). Moreover, 
the direction of the unique depression-endothelial function relationship was consistent when 
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depression was modeled alone (standardized coefficient = .11; p = .19) or with positive affect 
(standardized coefficient = .12; p = .21). Surprisingly, this relationship was in the opposite 
direction of that anticipated, as the unique depression components were related to numerically 
better endothelial function. This observation conflicts with a large prior literature linking 
depressive symptom severity to worse CVD outcomes in the general population (Bunker et al., 
2003; Cooper et al., 2011; Janssen et al., 2011; Pizzi et al., 2014; Stewart et al., 2012; Stewart et 
al., 2007; Van der Kooy et al., 2007). Confounding by antidepressant medication use, especially 
selective serotonin reuptake inhibitors (SSRIs) use, could be driving the depression-endothelial 
function relationship in the unanticipated direction, as the likelihood of being prescribed an 
antidepressant increases with depressive symptom severity (Dumesnil et al., 2012; Kendrick et 
al., 2009) and SSRI’s, in particular, may have cardiovascular benefits (Belcher, Drake-Holland, 
& Noble, 2005; Lekakis et al., 2010).  
Regarding the other Hypothesis 2 null results, unique anxiety was numerically, though 
not significantly, related to endothelial function (standardized coefficient = -.14; p = .31). The 
direction of this nonsignificant relationship is consistent with most of the previous literature, 
including a meta-analysis (Batelaan et al., 2016) revealing that anxiety increases the risk of 
incident CVD, even in studies that took depression into account. Unique positive affect did not 
relate to endothelial function (standardized coefficient = .01; p = .92), a result that adds to the 
mixed prior literature. Specifically, prior studies including depression as a covariate have found 
that either positive affect predicted future CVD outcomes (Davidson et al., 2010; Newman et al., 
2011; Kroenke et al., 2012) or was unrelated to CVD outcomes (Boehm et al., 2016; Hawkins et 
al., 2014; Kroenke et al., 2012). 
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My third hypothesis that traditional CVD risk status would partially mediate observed 
associations in the Aim 2 models was not supported, given that the 10-year Framingham risk 
score accounted for none of the detected relationship between unique hostility/anger and 
endothelial function. To my knowledge, this is the first study to examine traditional CVD risk 
status or risk factors as candidate mediators of affective trait-CVD outcome associations in 
depressed adults. Nonetheless, my null result is inconsistent with (1) the smaller literature 
involving depressed adults that supports positive associations between hostility/anger and total 
cholesterol levels (Fava et al., 1996; Fraguas et al., 2007), smoking (Fraguas et al., 2007), and 
inflammatory markers (Stewart et al., 2008; Suarez, 2003) and (2) the larger literature that 
supports inverse relationships between CVD risk factors and endothelial function (Hadi et al., 
2005). While it was surprising that we did not detect an inverse relationship between traditional 
CVD risk status and endothelial function, a meta-regression revealed that the relationship 
between 10-year Framingham risk score and brachial FMD was evident among adults at low 
CVD risk (<3% risk) but not among adults at medium or high CVD risk (>3% risk; Witte et al., 
2005). Importantly, the current study’s sample was mostly comprised of eIMPACT Trial 
participants, for which elevated CVD risk is an inclusion criterion. As a result, my sample had a 
mean Framingham risk score in the high CVD risk range, which may explain the lack of 
relationship between traditional CVD risk status and endothelial function.  
How Might Hostility/Anger Increase CVD Risk in Depressed Adults? 
My findings suggest that the unique hostility/anger components are associated with 
poorer endothelial function in depressed adults and that this relationship is not mediated by 
traditional CVD risk status. Given that hostility/anger has been consistently related to endothelial 
function (Cooper et al., 2010; Harris et al., 2003; Lin et al., 2008; Schott et al., 2009) and less 
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consistently related to later clinical CVD outcomes (Chida & Steptoe, 2009), this affective trait 
may be particularly cardiotoxic during the earlier stages of CVD. Additionally, if the 
hostility/anger-endothelial function relationship is not mediated by traditional CVD risk factors, 
then other candidate mechanisms should be examined. Emerging CVD risk factors hold promise 
for future investigations. In particular, systemic inflammation (a) has been found to drive early 
atherosclerotic progression, even in the absence of traditional risk factors (Libby, 2012), and (b) 
is associated with higher levels of hostility in adults with higher depressive symptoms but not in 
adults with lower depressive symptoms (Stewart et al., 2008; Suarez, 2003). Therefore, systemic 
inflammation is a candidate mediator of the hostility/anger-endothelial function relationship in 
depressed adults that should be tested in future studies. 
Methodological Limitations 
The present study’s results (a) may reflect the true state of nature or (b) may be due to 
methodological issues that interfere with my ability to detect the true state of nature (Kazdin, 
2002). While the preceding two sections discuss previous literature to elucidate the likelihood of 
explanation (a), methodological limitations that could have contributed to and methodological 
strengths that could have protected against explanation (b) are discussed below.  
First, suboptimal study design could explain inconsistencies with prior literature (Kazdin, 
2002). Because the present study was a cross-sectional examination of temporal hypotheses, the 
observed relationship between hostility/anger and endothelial function could be due to 
confounding, especially by preexisting medical conditions. While this possibility was minimized 
by excluding participants with clinical CVD, HIV/AIDS, chronic kidney disease, systemic 
inflammatory disease, or past-year cancer, not all preexisting medical conditions were taken into 
consideration. Some of these unconsidered medical conditions (e.g., diabetes, arthritis, and 
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chronic obstructive pulmonary disease) could contribute to both hostility/anger (Harrison, Falvo, 
Weiss, & Holland, 2017) and worsening cardiovascular health (Candido, Bernardi, & Allen, 
2009; Peters et al., 2009; Sin & Man, 2005). Therefore, the potential for confounding prevents 
me from interpreting my results as indicative of directional or causal relationships. 
Second, characteristics of the current sample could have affected measurement of key 
variables. Importantly, my older adult, higher CVD risk sample may have reduced FMD’s 
validity as a marker of endothelial function. One limitation of FMD is that it estimates 
endothelial function by presupposing a normal brachial artery structure (Maruhashi et al., 2013). 
However, blood vessels, including the brachial artery, become progressively stiffer with age and 
increasing CVD risk factors (Benetos et al., 2002). Increased arterial stiffness, in turn, may 
compromise the ability of the brachial artery to dilate, even in the presence of a functional 
endothelium. Consequently, in my sample, FMD may reflect a combination of endothelial 
function and arterial stiffness. While nitroglycerin-induced vasodilation, an index of 
endothelium-independent vasodilation, has been used as a control test to rule out this possibility 
(Corretti et al., 2002), it was not assessed in the present investigation due to safety concerns 
related to nitroglycerin administration. Therefore, my older adult, higher CVD risk sample may 
have increased error variance in the endothelial function measure, resulting in underestimation of 
the magnitude of relationships and an increased likelihood of type II errors. 
Third, although my study employed a theory-driven and rigorous analytic approach, there 
are also some drawbacks. Most notably, when modeling depression and hostility/anger together, 
LISREL modification indices suggested that the error of two pairs of indicators be correlated to 
improve model fit. Because I observed some conceptual/grammatical overlap between these 
pairs when examining questionnaire items, I correlated these errors as suggested. While these 
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post-hoc modifications enabled the model to achieve acceptable fit, they also inflated the chance 
of making a type I error (i.e., achieving fit indices that support an incorrect model). Thus, future 
research is needed to confirm this model and the hostility/anger-endothelial function relationship.  
Finally, my study was likely underpowered due to utilizing a sample size smaller than 
that of past epidemiologic studies examining affective trait-CVD outcome relationships. For 
example, the two previous studies that examined associations of affective traits’ shared variance 
with CVD outcomes had N’s > 1000 (Boyle et al., 2006; Kubzansky et al., 2006). Limited power 
likely decreased my ability to detect (a) relationships of interest and (b) well-fitting models. 
Possibility (a) is especially relevant for unique depression-endothelial function relationships, 
which appear to be of meaningful magnitude but fell short of significance. However, as 
previously mentioned, these relationships were in the opposite direction of that anticipated and 
potentially confounded by SSRI use. Possibility (b) is supported by the wide confidence intervals 
of the RMSEA estimates (see Table 3), which may reflect imprecision due to low power. A 
diminished ability to detect well-fitting models is most relevant for my shared variance models, 
which all failed to achieve acceptable fit. However, all shared variance models had poor fit in at 
least one index that is less influenced by sample size (i.e., SRMR and/or CFI; Iacobucci, 2010), 
suggesting that these poor fitting models may reflect true problems with modeling these shared 
variance constructs in depressed adults.  
Recommendations for Future Research 
Future research examining relationships between affective traits and CVD outcomes in 
depressed adults should: (1) use a prospective design to determine directionality of any observed 
relationships; (2) utilize a larger sample to ensure adequate power; (3) administer validated 
measures of multiple affective traits; (4) assess multiple CVD outcomes, such as subclinical 
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atherosclerosis and clinical events, to evaluate whether relationships change across the stages of 
atherosclerosis; (5) exclude or adjust for all important potential confounders, especially prevalent 
medical conditions and SSRI use, to rule out confounding as an explanation of any observed 
relationships; (6) test candidate mechanisms, including systemic inflammation, that may underlie 
detected relationships; and (7) ensure good variability in age and traditional CVD risk status to 
allow for examination of moderation by these factors.  
Several other recommendations pertain to modeling the shared and unique variance 
between affective traits in depressed adults. I recommend employing a theory-driven approach, 
such as SEM with confirmatory factor analysis, rather than exploratory approaches to maximize 
generalizability of the results beyond the sample. I also recommend investigating the unique and 
shared variance of various affective trait combinations (e.g., two versus three affective traits) in 
depressed adults to determine if a shared variance construct emerges only when a sufficient 
number of traits are examined. Finally, a strategy feasible with larger samples would be to 
randomly split that data and estimate models twice (Pohlmann, 2004) in order to provide 
validation for any suggested modification indices and reduce the likelihood of overfitting a 
model to the sample. 
Conclusions 
In this cross-sectional study, I found that hostility/anger (all components) and the unique 
hostility/anger components (those that do not overlap with depression) are both associated with 
poorer endothelial function in depressed older adults with elevated CVD risk. However, all of the 
other affective traits – i.e., depression, anxiety, positive affect, unique depression, unique 
anxiety, and unique positive affect – were not related to endothelial function. Finally, traditional 
CVD risk status did not mediate the observed relationship between unique hostility/anger and 
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endothelial function. Because this is the first study to simultaneously examine unique and all 
variance components of these affective traits in relation to CVD outcomes in depressed adults, 
future research is needed to replicate and extend my findings.  
If my results are supported by future findings, it would suggest that depressed adults with 
hostility/anger (a) may be a subgroup of the depressed population at greater risk of developing 
CVD and (b) may be in need of earlier, more intense, and/or different CVD primary prevention 
efforts. Regarding the latter, hostility/anger interventions have not typically been the focus of 
treatment for depressed adults but may be beneficial for reducing CVD risk in this group. Some 
evidence suggests that depressed adults with higher hostility/anger may be difficult to treat, as 
this group has been found to have greater depression severity and lower depression treatment 
response rates than depressed adults with low hostility/anger (Fisher et al., 2015). Nonetheless, 
initial research suggests that SSRIs are effective in reducing hostility/anger in those with (Fava et 
al., 1993) and without depression (Kamarck et al., 2009). Importantly, the latter study observed a 
specific treatment effect for the affective but not the behavioral or cognitive components of 
hostility/anger (Kamarck et al., 2009). Given the prior literature suggesting that depression is 
related more to attitudinal than motoric hostility/anger (Moreno, Fuhriman, & Selby, 1993), this 
specific treatment effect may indicate that SSRIs more effectively target the hostility/anger 
components shared with depression and that components not shared with depression may require 
additional forms of treatment. Of relevance to this idea, a pilot study reported benefit from 
adding an anticonvulsant to antidepressant medication for unipolar depressed patients presenting 
with prominent symptoms of anger, irritability, and hostility (Pasquini et al., 2007). However, 
additional research is needed to more definitively test this approach and, more generally, to 
determine how treatment should be optimized for adults with both depression and hostility/anger. 
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Importantly, treating hostility/anger may concurrently reduce CVD risk. For example, treating 
adults with hostility/anger with an SSRI appears to improve metabolic risk factors for CVD, such 
as waist circumference, fasting glucose, high-density lipoprotein cholesterol, and diastolic blood 
pressure (Kamarck et al., 2011). Despite the potential benefits of SSRI’s for depressed adults 
with hostility/anger, medication is a rare treatment choice for adults presenting with anger in 
medical settings (Ewigman, 2014). Therefore, if my results are supported by future studies, 
providers may benefit from screening for hostility/anger in depressed adults and leveraging 
available treatment options to address their patients’ negative affectivity and possibly reduce 
their patients’ CVD risk. 
In sum, the present findings advance understanding regarding whether there are 
subgroups of depressed adults at greatest CVD risk who may be driving the overall depression-
CVD relationship and may be in need of earlier, more intense, and/or different CVD primary 
prevention efforts.  
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Table 1  
Characteristics of Participants 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. Continuous variables are presented as M (SD), and categorical variables are presented as percentage. HTN Meds = 
antihypertensive medication. SBP = systolic blood pressure. FRS = Framingham risk score. SCL-20 = Symptom Checklist-20. 
GAD-7 = Generalized Anxiety Disorder 7. BPAQ = Buss-Perry Aggression Questionnaire. PANAS-PA = Positive and Negative 
Affect Schedule-Positive Affect subscale. Shaded indicates p < .05. 
a,b Matching letters (e.g., a and a) indicate a significant difference between values as determined by a Tukey’s post-hoc test for 
continuous variables or 2x2 chi-square for dichotomous variables 
  
Characteristic 
Total Sample 
(N = 138) 
eIMPACT 
(n = 94) 
INFLAMED 
(n = 17) 
 
BtB-Heart  
(n = 27) 
ANOVA or 2x3 
Chi-Square 
P Value 
Age, years 56.27 (7.1) 58.5a (5.5) 55.2b (8.1) 49.2ab (6.8) < .001 
Female, % 69 76a 65 48a .02 
Non-Hispanic Black, % 38 37 47 41 .67 
Less Than High School, % 18 22 6 11 .15 
Baseline Arterial Diameter, cm 0.40 (0.07) 0.40 (0.07) 0.39 (0.07) 0.41 (0.06) .10 
Diabetes, % (n = 137) 32 38a 35b 8ab .01 
Body Mass Index, kg/m2 (n = 137) 34.2 (10.0) 34.3 (10.0) 35.6 (12.5) 32.8 (8.4) .65 
HTN Meds, % (n = 136) 59 69ab 35a 39b .002 
SBP, mmHg (n = 136) 133.7 (19.2) 137.0a (19.2) 124.5a (18.0) 127.5 (17.0) .01 
Current Smoker, % 44 43 59 37 .35 
10-Year FRS (n = 133) 23.0 (14.4) 26.1a (14.6) 19.5 (12.7) 13.0a (8.0) < .001 
SCL-20 Score (n = 122) 1.8 (0.8) 1.9 (0.7) 1.7 (0.9) 1.5 (0.8) .18 
GAD-7 Score (n = 130) 10.4 (5.1) 10.5 (4.8) 10.5 (5.4) 10.0 (6.4) .93 
BPAQ Score (n = 113) 75.0 (20.4) 75.6 (20.6) 73.4 (22.1) 73.1 (19.8) .87 
PANAS-PA Score (n = 132) 27.2 (9.0) 27.4 (8.9) 27.1 (10.6) 26.6 (8.9) .94 
Flow-Mediated Dilation, % change 3.2 (2.6) 3.2 (2.3) 3.4 (3.2) 2.9 (3.1) .07 
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Table 2 
Correlations among Measures of Affective Traits, 10-Year Framingham Risk Score, and Endothelial Function  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. [Partial] = partial correlations controlling for age, sex, race/ethnicity, education, and baseline arterial diameter. SCL-20 = 
Symptom Checklist-20. GAD-7 = Generalized Anxiety Disorder 7. BPAQ = Buss-Perry Aggression Questionnaire. PANAS-PA = 
Positive and Negative Affect Schedule-Positive Affect subscale. FRS = Framingham risk score. Shaded indicates p < .05. 
  
Characteristic 
SCL-20 
Score 
GAD-7 
Score 
BPAQ 
Score 
PANAS 
Score 
10-Year 
FRS 
GAD-7 Score  .70     
GAD-7 Score [Partial] .72     
BPAQ Score  .10 .23    
BPAQ Score [Partial] .18 .22    
PANAS-PA Score  -.31 -.26 .03   
PANAS-PA Score [Partial] -.29 -.22 .04   
10-Year FRS  .07 .13 -.01 .02  
10-Year FRS [Partial] .13 .19 .15 -.08  
Flow-Mediated Dilation .09 .01 -.18 -.09 -.09 
Flow-Mediated Dilation [Partial] .10 .00 -.22 -.06 .01 
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Table 3 
Model Fit Indices 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. DEP = Depression. ANX = Anxiety. H/A = Hostility/Anger. PA = Positive Affect. EF = Endothelial Function. CVD risk = 
Traditional Cardiovascular Disease Risk Status. [m] = with modification indices. SRMR = Standardized Root Mean Square Residual. 
RMSEA = Root Mean Square of Approximation. CI = confidence interval. CFI = Comparative Fit Index. LISREL does not provide 
SRMR and CFI estimates for Model 11 because it uses full information maximum likelihood (FIML) estimation. 
Bold and shaded = Fit indices outside recommended guidelines for acceptable model fit (i.e., recommended cut-off values close to 
<.08 for SRMR, <.06 for RMSEA, and >.95 for CFI [Hu & Bentler, 1999] as well as a low model χ2 -statistic relative to degrees of 
freedom [χ2/df < 3:1 ratio] with an insignificant p value [p > 0.05] [Kline, 2005]). 
Model    df, N         χ2 (p) SRMR RMSEA (90% CI)  CFI 
Aim 1 Structural Models      
Model 1 (DEP – EF) 2, 138 .37 (.83) .01 .00 (.00, .10) 1.00 
Model 2 (ANX – EF) 2, 138 1.08 (.58) .02 .00 (.00, .14) 1.00 
Model 3 (H/A – EF) 2, 138 1.49 (.47) .02 .00 (.00, .16) 1.00 
Model 4 (PA – EF) 2, 138 3.39 (.18) .02 .07 (.00, .20) .99 
Aim 2 Measurement Models      
Model 5.1 (DEP, ANX) 8, 138 7.86 (.45) .02 .00 (.00, .10) 1.00 
Model 5.2 (DEP, ANX, Shared Variance) 9, 138 20.30 (.02) .32 .10 (.04, .15) .98 
Model 6.1a (DEP, ANG) 8, 138 26.33 (<.001) .04 .13 (.08, .19) .96 
Model 6.1b (DEP, ANG [m]) 6, 138 10.10 (.12) .03 .07 (.00, .14) .99 
Model 6.2 (DEP, ANG [m], Shared Variance) 7, 138 39.17 (<.001) .04 .18 (.13, .24) .89 
Model 7.1 (DEP, PA) 8, 138 3.95 (.86) .01 .00 (.00, .05) 1.00 
Model 7.2 (DEP, PA, Shared Variance) 9, 138 53.50 (<.001) .55 .19 (.14, .24) .81 
Aim 2 Structural Models      
Model 8 (DEP, ANX – EF) 12, 138 9.58 (.65) .02 .00 (.00, .07) 1.00 
Model 9 (DEP, ANG [m] – EF) 10, 138 11.21 (.34) .03 .03 (.00, .10) 1.00 
Model 10 (DEP, PA – EF) 12, 138 7.77 (.80) .02 .00 (.00, .06) 1.00 
Aim 3 Structural Model      
Model 11 (DEP, ANG [m] – CVD Risk – EF) 15, 138 14.81 (.47) --- .00 (.00, .08) --- 
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FIGURES 
 
 
 
Figure 1. Venn Diagram illustrating the unique depression variance (UD), unique anxiety 
variance (UA), and shared variance between depression and anxiety (D-A Shared).   
 
 
 
 
ANXIETY DEPRESSION 
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Figure 2. Venn diagram illustrating the potential relationships of unique depression variance 
(UD), unique anxiety variance (UA), and the shared variance between depression and anxiety 
(D-A Shared) with endothelial function. UD1 = unique depression variance shared with 
endothelial function. UD2 = unique depression variance not shared with endothelial function. 
UA1 = unique anxiety variance shared with endothelial function. UA2 = unique anxiety variance 
not shared with endothelial function. D-A Shared1 = shared variance between depression and 
anxiety shared with endothelial function. D-A Shared2 = shared variance between depression and 
anxiety not shared with endothelial function. 
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Figure 3. Models of Depression (Model 1), Anxiety (Model 2), Hostility/Anger (Model 3), and Positive Affect (Model 4) as 
predictors of Endothelial Function. Unidirectional arrows between variables are standardized regression coefficients and unidirectional 
arrows pointing at a single variable represent error variances. Paths with significant values are solid. Paths with nonsignificant values 
are dashed. SCL-20 = Symptom Checklist-20. GAD-7 = Generalized Anxiety Disorder 7. BPAQ = Buss-Perry Aggression 
Questionnaire. PANAS = Positive and Negative Affect Schedule-Positive Affect subscale. P1 = Parcel 1. P2 = Parcel 2. P3 = Parcel 3. 
FMD = flow-mediated dilation. N = 138. *Coefficient fixed to 1.0 prior to standardization. ^Error variance fixed to 0. 
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Figure 4. Model 8: Model of Depression and Anxiety as simultaneous predictors of Endothelial Function. Unidirectional arrows 
between variables are standardized regression coefficients and unidirectional arrows pointing at a single variable represent error 
variances. Paths with significant values are solid. Paths with nonsignificant values are dashed. SCL-20 = Symptom Checklist-20. 
GAD-7 = Generalized Anxiety Disorder 7. P1 = Parcel 1. P2 = Parcel 2. P3 = Parcel 3. FMD = flow-mediated dilation. N = 138. 
*Coefficient fixed to 1.0 prior to standardization. ^Error variance fixed to 0.  
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Figure 5. Model 9: Model of Depression and Hostility/Anger as simultaneous predictors of Endothelial Function. Unidirectional 
arrows between variables are standardized regression coefficients and unidirectional arrows pointing at a single variable represent 
error variances. Paths with significant values are solid. Paths with nonsignificant values are dashed. SCL-20 = Symptom Checklist-20. 
BPAQ = Buss-Perry Aggression Questionnaire. P1 = Parcel 1. P2 = Parcel 2. P3 = Parcel 3. FMD = flow-mediated dilation. N = 138. 
*Coefficient fixed to 1.0 prior to standardization. ^Error variance fixed to 0. 
  
1.0 
.15
1 
.80 
.97* 
.84 
SCL-20 P1 
SCL-20 P2 
SCL-20 P3 
.36 
.07 
.29 
Depression 
1.0 
0.0^ 
-.22 
.88 
.81 
.94* 
BPAQ P1 
BPAQ P2 
BPAQ P3 
.22 
.35 
.12 
Hostility/ 
Anger 
Endothelial 
Function 
1.0* 
FMD 
.07 
.07 
.21 
.94 
 
8
5
 
  86 
 
 
Figure 6. Model 10: Model of Depression and Positive Affect as simultaneous predictors of Endothelial Function. Unidirectional 
arrows between variables are standardized regression coefficients and unidirectional arrows pointing at a single variable represent 
error variances. Paths with significant values are solid. Paths with nonsignificant values are dashed. SCL-20 = Symptom Checklist-20. 
PANAS = Positive and Negative Affect Schedule-Positive Affect subscale. P1 = Parcel 1. P2 = Parcel 2. P3 = Parcel 3. FMD = flow-
mediated dilation. N = 138. *Coefficient fixed to 1.0 prior to standardization. ^Error variance fixed to 0. 
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Figure 7. Model 11: Model of Depression and Hostility/Anger as simultaneous predictors of Endothelial Function with Traditional 
Cardiovascular Disease Risk Status as a mediator between Hostility/Anger and Endothelial Function. Unidirectional arrows between 
variables are standardized regression coefficients and unidirectional arrows pointing at a single variable represent error variances. 
Paths with significant values are solid. Paths with nonsignificant values are dashed. SCL-20 = Symptom Checklist-20. BPAQ = Buss-
Perry Aggression Questionnaire. P1 = Parcel 1. P2 = Parcel 2. P3 = Parcel 3. FMD = flow-mediated dilation. FRS = Framingham Risk 
Score. CVD Risk = Traditional Cardiovascular Disease Risk Status. N = 138. *Coefficient fixed to 1.0 prior to standardization. ^Error 
variance fixed to 0. 
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APPENDIX A 
 
Inclusion/Exclusion Criteria for the Three Randomized Controlled Trials 
Inclusion/Exclusion Criteria A B C 
Demographic Criteria 
Primary care patient X X X 
Age ≥ 40 years X X  
Age ≥ 50 years   X 
Psychological Criteria 
Clinically significant depressive symptoms, defined as PHQ-9 score ≥ 10 X X X 
Two or more PHQ-9 items have been present at least “more than half the 
days” over the past 2 weeks, and one of the symptoms is either depressed 
mood or anhedonia 
  X 
No very severe depressive symptoms, defined as a PHQ-9 score ≥ 24  X  
No acute risk of suicide X X X 
No history of bipolar disorder or psychosis X X X 
No current alcohol use problem (i.e., ≥ 2 on CAGE questionnaire; Mayfield, 
McLeod, & Hall, 1974) 
X X  
No current evidence of abuse of prescription medications  X  
No current evidence of illicit drug use  X  
No severe cognitive impairment (i.e., ≥ 3 errors on 6 item cognitive screener; 
Callahan, Unverzagt, Hui, Perkins, & Hendrie, 2002) 
X X X 
No ongoing treatment for depression with a psychiatrist or psychologist/ 
counselor 
X   
No ongoing depression treatment with a psychiatrist outside of Eskenazi 
Health  
  X 
Medical Criteria 
Elevated CVD risk: ≥ 1 (if 60+ years) or ≥ 2 (if 50-59 years) of the following 
risk factors in medical record in past 5 years: hypertension, 
hypercholesterolemia, diabetes, or current smoking 
  X 
No history of clinical cardiovascular disease prior to enrollment (i.e., no 
coronary artery disease, cerebrovascular disease, acute myocardial infarction, 
percutaneous coronary intervention, or coronary artery bypass graphing) 
X X X 
No history of cardiac arrhythmias or cardiomyopathy  X  
No history of carotid bruits  X  
No history of the following chronic disorders: HIV/AIDS, chronic kidney 
disease, systemic inflammatory disease, or past-year cancer 
X X X 
No history of bleeding disorder, gastrointestinal ulceration or bleeding, 
cerebrovascular aneurysm or bleeding, or retinal hemorrhage 
 X  
No history of migraine headaches  X  
No history of Raynaud’s phenomenon  X  
No current use of anticoagulants X X X 
No current use of acetazolamide, anticonvulsants, or thyroid replacements    X  
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No current use of glucocorticoids – including topical, nasal, or oral steroids – 
or anabolic steroids 
 X  
No current use of anti-inflammatory agents  X  
No known allergy or intolerance to pentoxifylline or other methylxanthines, 
such as theophylline, caffeine, and theobromine 
 X  
No known allergy or intolerance to nitroglycerin  X  
No creatinine clearance < 50mL/min using a serum creatinine level at the pre-
treatment visit 
 X  
No hemoglobin < 9.0 mg/dL at the pre-treatment visit  X  
No alanine aminotransferase level or aspartate aminotransferase level > 3 
times the upper limit of normal at the pre-treatment visit 
 X  
No total bilirubin > 2.5 times the upper limit of normal at the pre-treatment 
visit 
 X  
No current pregnancy X X X 
Not currently breastfeeding  X  
Must be postmenopausal status for women (surgical menopause or the absence 
of menstruation in the past 12 months) or a history of tubal ligation  
 X  
Miscellaneous Criteria 
Must be able to lie flat for 30 minutes at a time X X  
No vision or hearing problems X X  
Must read and speak English X X  
Must use a computer at least once per year X   
Note. A = Beating the Blues for Your Heart Trial, B = INFLAMED Trial, C = eIMPACT Trial.  
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APPENDIX B 
 
Symptom Checklist 20 (SCL-20) 
Below is a list of problems and complaints that people sometimes have. Please read each one carefully. 
After you have done so, please check one of the spaces to the right that best describes HOW MUCH 
THAT PROBLEM HAS BOTHERED OR DISTRESSED YOU DURING THE PAST WEEK, 
INCLUDING TODAY. Mark only one space for each problem and do not skip any. 
How much were you bothered by: 
 See 
Response  
Options 
1. Loss of sexual interest or pleasure  
2. Feeling low in energy or slowed down  
3. Thoughts of ending your life  
4. Poor appetite  
5. Crying easily  
6. Feeling of being trapped or caught  
7. Blaming yourself for things  
8. Feeling lonely  
9. Feeling blue  
10. Worrying too much about things  
11. Feeling no interest in things  
12. Trouble falling asleep  
13. Feeling hopeless about the future  
14. Thoughts of death and dying  
15. Overeating  
16. Awakening in the early morning  
17. Sleep that is restless or disturbed  
18. Feeling everything is an effort  
19. Feelings of worthlessness  
20. Feelings of guilt  
Response options:  
1. Not at all 
2. A little bit 
3. Moderately 
4. Quite a bit 
5. Extremely 
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Generalized Anxiety Disorder 7-item (GAD-7) Scale 
Over the last 2 weeks, how often have you been bothered by the following problems? 
 See 
Response  
Options 
1.  Feeling nervous, anxious or on edge  
2.  Not being able to stop or control worrying  
3.  Worrying too much about different things  
4.  Trouble relaxing  
5.  Being so restless that it is hard to sit still  
6.  Becoming easily annoyed or irritable  
7.  Feeling afraid as if something awful might happen  
Response options: 
0. Not at all 
1. Several days 
2. More than half the days 
3. Nearly every day   
  92 
 
Buss Perry Aggression Questionnaire (BPAQ) 
Please indicate how uncharacteristic (unlike you) or characteristic (like you) each of the following 
statements is in describing you. Place a check mark on the point on the scale that you feel is most 
appropriate in describing you. 
 See 
Response 
Options 
1. Some of my friends think I am a hothead.  
2. If I have to resort to violence to protect my rights, I will.  
3. When people are especially nice to me, I wonder what they want.  
4. I tell my friends openly when I disagree with them.  
5. I have become so mad that I have broken things.  
6. I can't help getting into arguments when people disagree with me.  
7. I wonder why sometimes I feel so bitter about things.  
8. Once in a while, I can't control the urge to strike another person.  
9. I am an eventempered person.  
10. I am suspicious of overly friendly strangers.  
11. I have threatened people I know.  
12. I flare up quickly but get over it quickly.  
13. Given enough provocation, I may hit another person.  
14. When people annoy me, I may tell them what I think of them.  
15. I am sometimes eaten up with jealousy.  
16. I can think of no good reason for ever hitting a person.  
17. At times I feel I have gotten a raw deal out of life.  
18. I have trouble controlling my temper.  
19. When frustrated, I let my irritation show.  
20. I sometimes feel that people are laughing at me behind my back.  
21. I often find myself disagreeing with people.  
22. If somebody hits me, I hit back.  
23. I sometimes feel like a powder keg ready to explode.  
24. Other people always seem to get the breaks.  
25. There are people who pushed me so far that we came to blows.  
26. I know that "friends" talk about me behind my back.  
27. My friends say that I'm somewhat argumentative.  
28. Sometimes I fly off the handle for no good reason.  
29. I get into fights a little more than the average person.  
Response options: 
1. Extremely uncharacteristic of me 
2. Somewhat uncharacteristic of me 
3. Neither uncharacteristic nor characteristic of me 
4. Somewhat characteristic of me 
5. Extremely characteristic of me 
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The Positive and Negative Affect Schedule – Positive Affect (PANAS-PA) Scale 
This scale consists of a number of words and phrases that describe different feelings and 
emotions. Read each item and mark the appropriate answer next to that word. Indicate to what 
extent you have felt this way in general, that is, on average. 
 
 See 
Response 
Options 
1. Interested  
2. Excited  
3. Strong  
4. Enthusiastic  
5. Proud  
6. Alert  
7. Inspired  
8. Determined  
9. Attentive  
10. Active  
Response options: 
1. Very Slightly or Not at All 
2. A Little  
3. Moderately  
4. Quite a Bit  
5. Extremely 
